% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-08-23}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 1073.

\begin{enumerate}[leftmargin=*]
\item Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG (2026). \textit{A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251387655}{doi:10.1177/28314425251387655}.
\item Abrahms Zachary N., Majdi Mohammad, Madsen Siena M., Morton Chloe J., Sen Abhishek K., Fried Niya B., Sawyer Lily E., Cegielski Evelyn R., Spezzano Sean J., Jones J. Andrew (2026). \textit{Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases}. Metabolic Engineering. [published; Crossref]. \href{https://doi.org/10.1016/j.ymben.2026.102490}{doi:10.1016/j.ymben.2026.102490}.
\item Belle Buzzi (2026). \textit{Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://doi.org/10.25772/0t5k-3r51}{doi:10.25772/0t5k-3r51}.
\item Jaeckel LF, Logvinski D, Kanana M, Müller F, Rohner N, Becker AM, Liechti ME, Sterzer P. (2026). \textit{Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.}. Neuroscience of consciousness. [published; Europe PMC]. \href{https://doi.org/10.1093/nc/niag050}{doi:10.1093/nc/niag050}.
\item Mason, N. L.; Haijen-Bongers, E. C.; Kuypers, K. P. C.; Frick, A.; Toennes, S. W.; Mallaroni, P.; Ramaekers, J. G. (2026). \textit{Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.08.737179}{doi:10.64898/2026.07.08.737179}.
\item Yale University (2026). \textit{Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07306364}{source link}.
\item Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements (2026). \textit{Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21983116}{doi:10.5281/zenodo.21983116}.
\item Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B. (2026). \textit{Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.}. Journal of psychopharmacology (Oxford, England). [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261473436}{doi:10.1177/02698811261473436}.
\item Charles Raison (2026). \textit{An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07719088}{source link}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Brian Ross (2026). \textit{Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00517}{doi:10.1556/2054.2026.00517}.
\item Brigham and Women's Hospital (2026). \textit{Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296094}{source link}.
\item Anderson, D.; Maillot, N.; Thomas, C. W.; Golden, C. T.; Gilmour, G.; Robinson, E. S. (2026). \textit{Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning Task}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.06.743309}{doi:10.64898/2026.08.06.743309}.
\item Salgaço Mateus Kawata, Farias David de Paulo, Souza Mariela Zucolo de, Sartoratto Adilson, Bottino Flavia, Barud Hernane da Silva, Oliveira Fellipe Lopes de, Medeiros Alexandra Ivo de, Raimundo Breno Vilas Boas, Nascimento Victor Hugo, Galdino Taynah P., Silva Suédina M. L., Fook Marcus V. L., Sivieri Katia (2026). \textit{Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety}. Drugs and Drug Candidates. [published; Crossref]. \href{https://doi.org/10.3390/ddc5030046}{doi:10.3390/ddc5030046}.
\item Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria (2026). \textit{Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)}. Journal of Clinical Medicine. [published; Crossref]. \href{https://doi.org/10.3390/jcm15166228}{doi:10.3390/jcm15166228}.
\item NYU Langone Health (2026). \textit{Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06349083}{source link}.
\item Roswell Park Cancer Institute (2026). \textit{Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06827054}{source link}.
\item Kaadt E, Søkilde RF, Garling HD, Raval NR, Lundgaard L, Just J, Knudsen GM, Elfving B. (2026). \textit{Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.}. European journal of pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ejphar.2026.179222}{doi:10.1016/j.ejphar.2026.179222}.
\item Todesco S, Allan Z, Liu MYM, Schütz C. (2026). \textit{Effects of naturalistic psychedelic use on executive functioning: An online survey of lifetime history and recent use in university students.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111888}{doi:10.1016/j.pnpbp.2026.111888}.
\item Ke X, Du X, Wang X. (2026). \textit{Psychedelics and astrocytes: a hypothesis-driven perspective on neuro-glial integration, network plasticity, and neuroimmune reprogramming.}. Molecular psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03816-9}{doi:10.1038/s41380-026-03816-9}.
\item O’Shea A, Mason N, Schreiber R, Verheijen MC, Ramaekers JG, Briedé JJ, Krauskopf J. (2026). \textit{Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adults}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.04.742716}{doi:10.64898/2026.08.04.742716}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item University Health Network, Toronto (2026). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Dean JG, Hurwitz E, Furnish T, Castellanos J, McKinty A, Farrell B, Barrows D, Peck SK, Trim J, Samadhi E, Renwick G, Mudge R, Vieten C, Cuccurazzu B, Coleman P, Lin A, Geyer MA, Zeidan F, Halberstadt AL. (2026). \textit{Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.}. The journal of pain. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpain.2026.106404}{doi:10.1016/j.jpain.2026.106404}.
\item University of Southern California (2026). \textit{An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06233344}{source link}.
\item Chiu YT, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer KR, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL. (2026). \textit{A suite of engineered mice for interrogating psychedelic drug actions.}. Nature neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-026-02375-0}{doi:10.1038/s41593-026-02375-0}.
\item Li, Z.; Weber, C.; Sellitti, F.; Simmler, L. D. (2026). \textit{Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.31.741703}{doi:10.64898/2026.07.31.741703}.
\item Ippolito A, Tiranti A, Hurley S, Gilmour G, Churchill G, Sharp T (2026). \textit{Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00138}{doi:10.1021/acschemneuro.6c00138}.
\item Kuypers KPC, Mason NL, Carlier A, Totomanova I, Haijen-Bongers ECHM. (2026). \textit{Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.}. Molecular psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03801-2}{doi:10.1038/s41380-026-03801-2}.
\item Martin, H. M.; Cofre, R.; Destexhe, A. (2026). \textit{Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.20.683366}{doi:10.1101/2025.10.20.683366}.
\item Frederik Gudmundsen, Julia Czurylo, Daniel Ryskamp Rijsketic, Camilla Trang Vo, Janika Ruuska, Naja S. Jessen, Sophie Woodruff, Christina Baun, Matthias M. Herth, Vladimir Shalgunov, Boris D. Heifets, Patrick M. Fisher, Mikael Palner (2026). \textit{Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-026-75890-0}{doi:10.1038/s41467-026-75890-0}.
\item Akbar Razeen J., Stringer Amy D., Wiah Sonita, Dachepalli Meghana, Daws Stephanie E., Inan Saadet, Rawls Scott M. (2026). \textit{Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000879}{doi:10.1097/fbp.0000000000000879}.
\item Vicentini AB, de Paula CC, Silva Reis JA, Bouso JC, Hallak JEC, Dos Santos RG (2026). \textit{Classic psychedelics and personality: An updated systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item Boehnke KF, Pouyan N, Aday JS (2026). \textit{Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-026-02339-5}{doi:10.1007/s40265-026-02339-5}.
\item Lu S, Zhang Z, Xue X, Jiang Y, Zhang C, Liu P, He D, Shen W, Yang S, Wang F (2026). \textit{Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.}. Hearing research. [published; PubMed]. \href{https://doi.org/10.1016/j.heares.2026.109701}{doi:10.1016/j.heares.2026.109701}.
\item Potoczna M, Kasica N, Chmielewska-Krzesińska M, Dybalska-Szczepanek J, Wąsowicz K, Sokołowska E, Podlasz P (2026). \textit{Anxiety-related platform in zebrafish (Danio rerio) larvae: An integrated analysis of behavioural and molecular assay in drug screening research.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2026.119680}{doi:10.1016/j.biopha.2026.119680}.
\item Graham M, Ge Y, Pacula RL, Pessar SC, Wilkins C, Hall W, Hammond D (2026). \textit{A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2026.105348}{doi:10.1016/j.drugpo.2026.105348}.
\item Sergio R Pérez Rosal, Sonya Faber, M. Myriah MacIntyre, Monnica Williams (2026). \textit{Retreat from racism: A psychedelic group experience for racial stress and trauma}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2026.100031}{doi:10.1016/j.psyche.2026.100031}.
\item Jones GH, Gilbert JR, Johnston JN, Akula N, Schulmann A, Arakelian M, Peng S, Yuan P, Winful EA, Yavi M, Quintanilla B, Elkahloun A, Moaddel R, Henter ID, Greenstein D, Machado-Vieira R, Bartley CM, Kadriu B, Amit M, Rezvani K, Kvarta MD, McMahon FJ, Zarate CA (2026). \textit{Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03777-z}{doi:10.1038/s41380-026-03777-z}.
\item Fleury S, Chang LJ, Nautiyal KM. (2026). \textit{Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse models}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.24.740586}{doi:10.64898/2026.07.24.740586}.
\item Wilkowska A, Nizgorska-Ohler J, Cubała WJ (2026). \textit{Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.}. Molecular neurobiology. [published; PubMed]. \href{https://doi.org/10.1007/s12035-026-06086-2}{doi:10.1007/s12035-026-06086-2}.
\item Pereira de Oliveira AB, Hein M (2026). \textit{[Illicit use of classic psychedelics and suicidality: A systematic literature review].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2026.04.004}{doi:10.1016/j.encep.2026.04.004}.
\item O'Callaghan C, Kallianis V, Ross M (2026). \textit{Participants' Music Experiences Associated With Psychedelic-Assisted Psychotherapy for Life-Threatening Illness: Interpretivist Research.}. Journal of music therapy. [published; PubMed]. \href{https://doi.org/10.1093/jmt/thag015}{doi:10.1093/jmt/thag015}.
\item Johns Hopkins University (2026). \textit{Psilocybin and Affective Function in Chronic Lower Back Pain Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06355414}{source link}.
\item Tyler WJ, Sellers E, McDonnell MB. (2026). \textit{Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response Model}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.19.739440}{doi:10.64898/2026.07.19.739440}.
\item Ohio State University (2026). \textit{A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06820723}{source link}.
\item Pallavicini Carla, Llobenes Lorena, Cavanna Federico, de la Fuente Laura Alethia, Muller Stephanie, Costa María, Gumiy Natali, Bruno Nicolás, D'Amelio Tomás, Basran Jaskaran, Plowright Ptarmigan, Zamberlan Federico, Pasqualetti Guillermo, Stolkiner Ain, Namías Mauro, Gilbert Paul, Tagliazucchi Enzo (2026). \textit{Longitudinal neural and psychological changes following psilocybin under compassion imagery priming}. Frontiers in Human Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnhum.2026.1874178}{doi:10.3389/fnhum.2026.1874178}.
\item Johns Hopkins University (2026). \textit{PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610135}{source link}.
\item Savalia NK, Shao LX, Knox CA, Gilbert AD, Jiang Q, Kwan AC (2026). \textit{Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.16.738983}{doi:10.64898/2026.07.16.738983}.
\item Gattuso James J., Kamal Ahmed, Payet Jennyfer M., Havaux Kato, Hendey Jenna, Bezcioglu Bilgenur, Phelan Zoe J., Orchard Maddy, Bhanot Divyesh, Hale Matthew W., Hannan Anthony J., Renoir Thibault (2026). \textit{Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-026-02501-3}{doi:10.1038/s41386-026-02501-3}.
\item Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś, Lidia Kozaczko, Gabriela Szewczyk, Elżbieta Bukowczan, Alicja Zając, Damian Broda, Alicja Benecka (2026). \textit{Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21406174}{doi:10.5281/zenodo.21406174}.
\item Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech, Grzegorz Kasparek, Adrianna Szczecińska, Wiktoria Glanert, Aleksandra Mliczek, Piotr Mrozek (2026). \textit{Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2026.94.73071}{doi:10.12775/jehs.2026.94.73071}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Hidalgo Jiménez J, Martín-Guerrero SM, González-Maeso J, López-Giménez JF (2026). \textit{Integrated 5-HT-TrkB and G protein signaling in serotonergic psychedelic responses.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03746-6}{doi:10.1038/s41380-026-03746-6}.
\item Johansen A, Plavén-Sigray P, Madsen MK, Søndergaard A, Messel C, Geisler M, Nasser A, McCulloch DE, Beliveau V, Vassilieva A, Lund A, Lehel S, Ozenne B, Stenbæk DS, Fisher PM, Svarer C, Knudsen GM (2026). \textit{Psilocybin's effect on human brain synaptic plasticity.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-026-04285-y}{doi:10.1038/s41398-026-04285-y}.
\item Khyber Medical University Peshawar (2026). \textit{Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07703722}{source link}.
\item Brinzei OV. (2026). \textit{MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments}. ScienceOpen Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.14293/pr2199.004090.v1}{doi:10.14293/pr2199.004090.v1}.
\item Lin C, Wang X (2026). \textit{Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03744-8}{doi:10.1038/s41380-026-03744-8}.
\item University of California, Berkeley (2026). \textit{Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05265546}{source link}.
\item Liu C, Ho EM, Enos AS, Baublyte UB, Luna IM, Kosche AR, Sohal VS (2026). \textit{Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.05.736652}{doi:10.64898/2026.07.05.736652}.
\item Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo (2026). \textit{Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/guqxr}{doi:10.17605/osf.io/guqxr}.
\item University of Pennsylvania (2026). \textit{Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06810310}{source link}.
\item Baker JJ, Kogan E, Ma S, Lu J, Zuo Y (2026). \textit{Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.06.716778}{doi:10.64898/2026.04.06.716778}.
\item Paslawski Wojciech, Doyon Daniel, Ekman Carl Johan, Yngwe Hampus, Mamula Dejan, Zareba-Paslawska Justyna, Beckman Maria, Xu Zhi-Qing David, Hökfelt Tomas, Tiger Mikael, Lundberg Johan, Svenningsson Per (2026). \textit{CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-026-02490-3}{doi:10.1038/s41386-026-02490-3}.
\item Matthew A. Boehm, Oriana Mayorga (2026). \textit{Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280103}{doi:10.38126/jspg280103}.
\item Koning Elena, Richard Jérémie, Keshen Aaron (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions}. International Journal of Eating Disorders. [published; Crossref]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Askari M, Surapaneni V. (2026). \textit{Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2fd49}{doi:10.32942/x2fd49}.
\item Pasquini Lorenzo, Vohryzek Jakub, Escrichs Anira, Perl Yonatan Sanz, Ponce-Alvarez Adrian, Idesis Sebastian, Girn Manesh, Roseman Leor, Mitchell Jennifer M., Gazzaley Adam, Kringelbach Morten, Nutt David J., Lyons Taylor, Carhart-Harris Robin L., Deco Gustavo (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits}. Human Brain Mapping. [published; Crossref]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Allen Josh, Jupp Bianca, Baker Tamara L., Haskali Mohammad B., Brkljača Robert, Plummer Zoe, Sun Mujun, Brand Justin, Christie Brian R., Debert Chantel T., McDonald Stuart J., O’Brien Terence J., Casillas-Espinosa Pablo M., Shultz Sandy R. (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats}. Cell Reports Medicine. [published; Crossref]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T (2026). \textit{Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70109}{doi:10.1111/bph.70109}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Ascone F, Buzzelli V, Mottarlini F, Di Trapano M, Miglioranza P, Rava A, Feo A, Spano F, Hausman M, Sugaya K, Caffino L, Fumagalli F, Trezza V (2026). \textit{Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02361-x}{doi:10.1038/s41386-026-02361-x}.
\item Wang Y, Wang H, Lin C, Wang X (2026). \textit{Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2535785123}{doi:10.1073/pnas.2535785123}.
\item Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.}. Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. [published; PubMed]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Johns Hopkins University (2026). \textit{5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05452772}{source link}.
\item Du Yingjie, Zhao Xiangting, Yao Yishan, Li Yunfeng, Wang Guyan, Zhang Liming (2026). \textit{Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261453819}{doi:10.1177/02698811261453819}.
\item Anthony P King (2026). \textit{A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07104916}{source link}.
\item Claudino Dos Santos JC, Bolan SJ, Lodetti G, Viana GL, Rico EP, Gonçalves CL (2026). \textit{Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2026.06.035}{doi:10.1016/j.jpsychires.2026.06.035}.
\item Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti (2026). \textit{Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04203-2}{doi:10.1038/s41398-026-04203-2}.
\item Yale University (2026). \textit{Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07449351}{source link}.
\item van den Busken WJ, Dines AM, Eyer F, Heyerdahl F, Hovda KE, Liechti ME, Miró Ò, Vallersnes OM, Wood DM, Yates C, Dargan PI, (on behalf of the Euro-DEN Plus Research Group), Gresnigt FMJ, Euro-DEN Plus Research Group (2026). \textit{Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2669671}{doi:10.1080/15563650.2026.2669671}.
\item Low ZXB (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Eric P. Rubenstein (2026). \textit{Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use}. Journal of Advances in Developmental Research. [published; OpenAlex]. \href{https://doi.org/10.71097/ijaidr.v17.i1.1997}{doi:10.71097/ijaidr.v17.i1.1997}.
\item Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G. (2026). \textit{Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.12.731811}{doi:10.64898/2026.06.12.731811}.
\item SAIMSARA (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA}. SAIMSARA Journal. [published; Crossref]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj (2026). \textit{THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5605}{doi:10.31435/ijitss.2(50).2026.5605}.
\item Theo Tobel, Aidan Cone, Emily M Choquette, McKenna Garland, Micah Johnson, Keller Mink, Caitlin Lynch, Joel Frohlich, Justin Feinstein, Nicco Reggente (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v2}{source link}.
\item Jennifer Mitchell (2026). \textit{A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07386730}{source link}.
\item Yale University (2026). \textit{Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05370911}{source link}.
\item Dorval Michel, Audet-Croteau Virginie, Chang Sue-Ling, Masse-Grenier Marianne, Tremblay Annie, Bénard Elodie, Chapdelaine Alexandra, Garel Nicolas, Guertin Jason Robert (2026). \textit{Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation}. Healthcare. [published; Crossref]. \href{https://doi.org/10.3390/healthcare14111559}{doi:10.3390/healthcare14111559}.
\item Kelly JR, Sheridan C, Iusan P, Coakley L, Burke L, Brennan C, MacDonald A, Ivers JH, Trepel D, Tormey G, Finnegan M, Young GW, Harkin A (2026). \textit{Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyag028}{doi:10.1093/ijnp/pyag028}.
\item Pastre M., Pereira F., Gibert T., Giron A., Goemare B., Olié E., Courtet P., Lopez-Castroman J., Conejero I. (2026). \textit{One dose of Psilocybin modulates Brain Activity among Depressive patients: Preliminary Neuroimaging Results from the PSILODAC Study}. European Psychiatry. [published; Crossref]. \href{https://doi.org/10.1192/j.eurpsy.2026.10729}{doi:10.1192/j.eurpsy.2026.10729}.
\item M. Pastuszak, K. Jakuszkowiak-Wojten, M. Gałuszko-Węgielnik, A. W. Kwaśny, A. Mechlińska, D. Świeczkowski, W. J. Cubała (2026). \textit{A Molecule-Resolved Bibliometric Analysis of PubMed-Indexed Psychedelic Research (2015-2025): Volume, Temporal Trends, and Publication Types}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2026.11510}{doi:10.1192/j.eurpsy.2026.11510}.
\item Udoro AJ, Yukyi Y, Ansari AZ, Gandara HA, Ahmed F, Hunt D (2026). \textit{Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.110791}{doi:10.7759/cureus.110791}.
\item Fotiadis P, Jang H, Dai R, Li D, Cofré R, Timmermann C, Mashour GA, Hudetz AG, Huang Z (2026). \textit{Reorganization of Human Brain Waves Across Diverse States of Consciousness.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.05.27.728182}{doi:10.64898/2026.05.27.728182}.
\item Miller CWT, Kozak Z (2026). \textit{Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens.}. Psychodynamic psychiatry. [published; PubMed]. \href{https://doi.org/10.1521/pdps.2026.54.2.308}{doi:10.1521/pdps.2026.54.2.308}.
\item Poppe C, Lyck L, Bechtold L, Repantis D (2026). \textit{Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71544}{doi:10.1002/brb3.71544}.
\item Rowe T, Hurzeler T, Towers E, Louie E, Morley KC (2026). \textit{Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71533}{doi:10.1002/brb3.71533}.
\item Lago Marcos, Cerveira Mariana, Simonet Joe Xavier (2026). \textit{Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report}. Frontiers in Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnins.2026.1813281}{doi:10.3389/fnins.2026.1813281}.
\item Urban Marvin M., Zillich Lea, Rieser Nathalie M., Herdener Marcus, Spanagel Rainer, Vollenweider Franz X., Preller Katrin H., Meinhardt Marcus W. (2026). \textit{Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder}. Translational Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41398-026-03961-3}{doi:10.1038/s41398-026-03961-3}.
\item Naja Bralic, Elena Bragagnolo, Mikael Palner (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Cocaine Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02037126}{source link}.
\item University of Calgary (2026). \textit{Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06885996}{source link}.
\item Kwiatos N, Ossel S, Mutti FG (2026). \textit{Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole-Cell Factory Saccharomyces Cerevisae.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202500898}{doi:10.1002/cbic.202500898}.
\item Khadija Kamene (2026). \textit{Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care}. Premier Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.70389/pjn.100014}{doi:10.70389/pjn.100014}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item Forsyth Dayna, Faraone Nicoletta, Lamarre Simon G., Currie Suzanne (2026). \textit{The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus}. Frontiers in Behavioral Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnbeh.2026.1767175}{doi:10.3389/fnbeh.2026.1767175}.
\item Hecker L, Kleinhenz J M, Coarfa C, Kato K (2026). \textit{C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung Diseases}. American Journal of Respiratory and Critical Care Medicine. [published; Crossref]. \href{https://doi.org/10.1093/ajrccm/aamag162.144}{doi:10.1093/ajrccm/aamag162.144}.
\item Greenway KT, Garel N, Dinh-Williams LL, Thibault Lévesque J, Kaelen M, Dagenais-Beaulé V, de la Salle S, Erritzoe D, Looper K, Turecki G, Rej S, Richard-Devantoy S (2026). \textit{The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.2025.102}{doi:10.1192/bjp.2025.102}.
\item Diehl VJ, Calder AE, Hasler G (2026). \textit{The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251397306}{doi:10.1177/02698811251397306}.
\item Garcia Garcia M, Belahda D, Graux C, Serrand C, Igounenc N, Sergent F, Mura T, Luquiens A (2026). \textit{Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2026.121215}{doi:10.1016/j.jad.2026.121215}.
\item Domi Ana, Lucente Erika, Cadeddu Davide, Bengtsson Niklas, Smedler Erik, Adermark Louise (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms}. Neuropharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Gillet A, Geron C, Vitello MM, Lejeune N (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Silva MH (2026). \textit{New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants.}. Birth defects research. [published; PubMed]. \href{https://doi.org/10.1002/bdr2.70048}{doi:10.1002/bdr2.70048}.
\item Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A (2026). \textit{Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.}. Cancer reports (Hoboken, N.J.). [published; PubMed]. \href{https://doi.org/10.1002/cnr2.70587}{doi:10.1002/cnr2.70587}.
\item Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar (2026). \textit{Evaluating the evidence for repressed memory recovery in psychedelic contexts}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07076-x}{doi:10.1007/s00213-026-07076-x}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Neil K. Savalia, Lingxiao Shao, Cory Knox, A. Gilbert, Quan Jiang, Alex Kwan (2026). \textit{157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.391}{doi:10.1016/j.biopsych.2026.03.391}.
\item Hinchcliffe JK, Bartlett J, Thomas CW, Golden CT, Gilmour G, Bortolotto ZA, Robinson ES. (2026). \textit{Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.20.719483}{doi:10.64898/2026.04.20.719483}.
\item Drange Sivert, Cohen Jacob, Johansen Sys Stybe, Dunkley Ben, Palner Mikael (2026). \textit{Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins}. Frontiers in Psychiatry. [published; Crossref]. \href{https://doi.org/10.3389/fpsyt.2026.1819962}{doi:10.3389/fpsyt.2026.1819962}.
\item Brinzei OV. (2026). \textit{Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 Update}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1423.v1}{doi:10.20944/preprints202604.1423.v1}.
\item Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.}. Current issues in molecular biology. [published; PubMed]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item Minauro-Sanmiguel F, Vargas-Perez H (2026). \textit{Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes.}. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroscience.2026.02.028}{doi:10.1016/j.neuroscience.2026.02.028}.
\item Berman P, Höfer J, Mehlman H, Almekias-Siegl E, Khersonsky O, Dong Y, Heinig U, Sulimani L, Hao LK, Cohen S, Peleg Y, Meir S, Rogachev I, Meiri D, Fleishman SJ, Aharoni A (2026). \textit{Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.}. Science advances. [published; PubMed]. \href{https://doi.org/10.1126/sciadv.aeb3034}{doi:10.1126/sciadv.aeb3034}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05546658}{source link}.
\item Meshkat Shakila, Jha Manish K., Bhat Venkat (2026). \textit{Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications}. Focus. [published; Crossref]. \href{https://doi.org/10.1176/appi.focus.20250043}{doi:10.1176/appi.focus.20250043}.
\item Kazdan J, Ladha KS, Husain MI (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.}. Pharmacology research \& perspectives. [published; PubMed]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, Vollenweider FX, Ramaekers JG, Kuypers K, Araujo DB, Sporns O, Siegel J, Dosenbach N, Nutt DJ, Carhart-Harris RL, Stamatakis EA, Bzdok D (2026). \textit{An international mega-analysis of psychedelic drug effects on brain circuit function.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/s41591-026-04287-9}{doi:10.1038/s41591-026-04287-9}.
\item Marazziti D, Gambini M, Gurrieri R, Russomanno G, Sità G, Pescini E, Digiuseppe FR, Mucci F (2026). \textit{Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.}. Expert opinion on pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1080/14656566.2026.2654682}{doi:10.1080/14656566.2026.2654682}.
\item Saif S. Ali, Robin L. Carhart-Harris, Karl G. Sieg (2026). \textit{Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00626-4}{doi:10.1038/s44220-026-00626-4}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Zirkel RT, Isaacson M, Liao C, Yi M, Yamaguchi K, Rivera D, Kuceyeski A, Nishimura N, Kwan AC, Schaffer CB (2026). \textit{Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.07.25.666803}{doi:10.1101/2025.07.25.666803}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Jiménez JH, Martín-Guerrero SM, González-Maeso J, López-Giménez JF (2026). \textit{Integrated 5-HT -TrkB and G protein signaling in serotonergic psychedelic responses.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.03.19.712961}{doi:10.64898/2026.03.19.712961}.
\item University of New Mexico (2026). \textit{Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07484906}{source link}.
\item Farré-Colomés Àlvar, Rublinetska Olga, Soto-Angona Óscar (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies}. Discover Mental Health. [published; Crossref]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item Wood BJ, Vest MF, Carfagno C, Bartley KR, Sharma P, Halberstadt AL, Blough BE, Murnane KS (2026). \textit{Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00484}{doi:10.1021/acsptsci.5c00484}.
\item University of Alabama at Birmingham (2026). \textit{Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227742}{source link}.
\item Chauhan SB, Akhtar N, Jain C, Singh I (2026). \textit{Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.}. CNS \& neurological disorders drug targets. [published; PubMed]. \href{https://doi.org/10.2174/0118715273434237251212095005}{doi:10.2174/0118715273434237251212095005}.
\item Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP. (2026). \textit{Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.06.710108}{doi:10.64898/2026.03.06.710108}.
\item Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric (2026). \textit{Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00364}{doi:10.1556/2054.2025.00364}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Stanley Kisourin (2026). \textit{Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and Neuroprotection}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18825289}{doi:10.5281/zenodo.18825289}.
\item Wrathall David J., Gosnell Hannah, Wickson Fern, Spanger Erika, Associates* (2026). \textit{Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward}. Action Research. [published; Crossref]. \href{https://doi.org/10.1177/14767503251404263}{doi:10.1177/14767503251404263}.
\item Guo Cui, Luu Nguyen N.T., Adwer Maryem M., Hosseinzadeh Hemen, Balan Venkatesh, Yan Yajun, Lin Yuheng (2026). \textit{Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocin}. Metabolic Engineering. [published; Crossref]. \href{https://doi.org/10.1016/j.ymben.2025.11.002}{doi:10.1016/j.ymben.2025.11.002}.
\item Xu T, Wong S, Le GH, Dri CE, Teopiz KM, Lu A, Lee S, Rhee TG, Yin L, Bargiota S, Ho R, McIntyre RS (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Shokr MM, Fawzy MN, Abdelaziz AM (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Molecular and cellular neurosciences. [published; PubMed]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo (2026). \textit{A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253261433836}{doi:10.1177/20451253261433836}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item Jacobs E, Zahid Z, Hinkle J, Nayak S, Yaden DB (2026). \textit{Psychedelic medicine: mechanisms, evidence, and translation to practice.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2024-081723}{doi:10.1136/bmj-2024-081723}.
\item Murray Z, Lewies A, Wentzel JF, Schutte-Smith M, Erasmus E, Noreljaleel A, Visser H, Wilhelm A, Issahaku AR (2026). \textit{Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-026-39483-7}{doi:10.1038/s41598-026-39483-7}.
\item Dolenec P, Pelčić G, Pilipović K, Mršić-Pelčić J, Hrkać AH (2026). \textit{Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph19020316}{doi:10.3390/ph19020316}.
\item Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C (2026). \textit{Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.}. Research square. [published; PubMed]. \href{https://doi.org/10.21203/rs.3.rs-8733841/v1}{doi:10.21203/rs.3.rs-8733841/v1}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501568}{doi:10.5281/zenodo.18501568}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501514}{doi:10.5281/zenodo.18501514}.
\item Liu Junhong, Wang Yuanyuan, Xia Ke, Wu Jinfeng, Zheng Danhao, Cai Aoling, Yan Haitao, Su Ruibin (2026). \textit{Acute psilocin increased cortical activity in rat}. Frontiers in Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnins.2026.1593703}{doi:10.3389/fnins.2026.1593703}.
\item Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Bostancıklıoğlu M, Kaplan DS, Bal R, Yiğit E, Ulusal H, Temiz E (2026). \textit{MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2026.01.016}{doi:10.1016/j.biopsych.2026.01.016}.
\item Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN (2026). \textit{Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437251389090}{doi:10.1177/07067437251389090}.
\item Kramer HM, Hibicke M, Middleton J, Jaster AM, Kristensen JL, Nichols CD (2026). \textit{Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-025-02272-3}{doi:10.1038/s41386-025-02272-3}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M (2026). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS (2026). \textit{Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106516}{doi:10.1016/j.neubiorev.2025.106516}.
\item Dutton M, Schwenn P, Mitchell J, Hoffmann P, Bailey NW, Fitzgerald PB, Lagopoulos J, Can AT (2026). \textit{Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674251398677}{doi:10.1177/00048674251398677}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M (2026). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Halm S (2026). \textit{Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71265}{doi:10.1002/brb3.71265}.
\item McNaughton N, Shadli SM, Beaglehole B, Glue P (2026). \textit{Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.}. Journal of the Royal Society of New Zealand. [published; PubMed]. \href{https://doi.org/10.1002/snz2.70002}{doi:10.1002/snz2.70002}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Kristensen J (2026). \textit{Regarding "The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses".}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-026-03844-7}{doi:10.1038/s41398-026-03844-7}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska (2026). \textit{Psychedelics in psychiatric treatment: a literature review}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.50.68013}{doi:10.12775/qs.2026.50.68013}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item de la Fuente Revenga M, González-Maeso J (2026). \textit{Snapshot IP Detection Following 5-HTA Receptor Stimulation in the Mouse Brain.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00932}{doi:10.1021/acschemneuro.5c00932}.
\item Kandilakis CL, Papatheodoropoulos C (2026). \textit{Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00892}{doi:10.1021/acschemneuro.5c00892}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al. (2026). \textit{Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000793359}{doi:10.3929/ethz-c-000793359}.
\item Xia K, Gao T (2026). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. [published; PubMed]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Larsen K, Fisher PM, McCulloch DE, Olsen AS, Mueller F, Liechti M, Borgwardt S, Holze F, Vizeli P, Ley L, Klaiber A, Becker A, Ozenne B, Avram M. (2026). \textit{Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.01.15.26344193}{doi:10.64898/2026.01.15.26344193}.
\item Theo Tobel, Aidan Cone, Emily M Choquette, McKenna Garland, Micah Johnson, Keller Mink, Caitlin Lynch, Joel Frohlich, Justin Feinstein, Nicco Reggente (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v1}{source link}.
\item Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES. (2026). \textit{Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.01.14.699553}{doi:10.64898/2026.01.14.699553}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS (2026). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item University of California, San Diego (2026). \textit{Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05224336}{source link}.
\item Cornelius T, Barba T (2026). \textit{Associations of Couples' Psychedelic Use with Shared Reality and Relational Well-Being.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2607729}{doi:10.1080/02791072.2025.2607729}.
\item Slot J, Bradshaw A, Dentinger B, Borovička J, Konkel Z, Rockefeller A, Bollinger I. (2026). \textit{The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in Psilocybe}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.30.697041}{doi:10.64898/2025.12.30.697041}.
\item Federico Durbano, Marco Otto Toscano (2026). \textit{Psychedelic Drugs}. IntechOpen. [published; OpenAlex]. \href{https://www.intechopen.com/books/1004886}{source link}.
\item CA Madsen, M. Navarro, E. Kolesnik, D. Kazani, V. Shalgunov, M. Zabrocki, A. Nasser, D. Luethi, F. Holze, M.E. Liechti, S.S. Johansen, M.K.K. Nielsen, H.D. Hansen, G.M. Knudsen (2026). \textit{Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigs}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106824}{doi:10.1016/j.nsa.2025.106824}.
\item Marecki R, Zaniewska W, Hamed A, Waszkiewicz N, Baker JJ, Łukasiewicz K (2026). \textit{Sex-dependent effects of psychedelics: review of evidence from rodent models.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1824073}{doi:10.3389/fpsyt.2026.1824073}.
\item Stefan Jerotić, Olga Čolović, Nađa Marić (2026). \textit{Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"}. Medicinska istrazivanja. [published; OpenAlex]. \href{https://doi.org/10.5937/medi0-62051}{doi:10.5937/medi0-62051}.
\item Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah (2026). \textit{‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury}. Internal Medicine Journal. [published; OpenAlex]. \href{https://doi.org/10.1111/imj.70313}{doi:10.1111/imj.70313}.
\item Choi C, Johnson DE, Chen-Li D, Rosenblat J (2026). \textit{Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241286771}{doi:10.1177/02698811241286771}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM (2026). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Heal DJ, Gosden J, Smith SL (2026). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Lewis S (2026). \textit{'Magic' mechanisms underlie psilocybin's effects in chronic pain.}. Nature reviews. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41583-025-00999-y}{doi:10.1038/s41583-025-00999-y}.
\item Konstantinou GN, Rosenblat J, Hales S, Husain MI, Blumberger DM (2026). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Maltby CJ, Klein AK, Paschen E, Pinto J, Dvorak D, Hedde JR, Hanks AN, Bianchi M, Hughes ZA (2026). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Moghadam H, Akbari P, Beirami E, Nabavifard S, Ameli A, Valian N (2026). \textit{The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.}. Journal of neuroscience research. [published; PubMed]. \href{https://doi.org/10.1002/jnr.70107}{doi:10.1002/jnr.70107}.
\item Rasheed S, Arif R, Raza AA, Samadi A (2026). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.}. Annals of medicine and surgery (2012). [published; PubMed]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W (2026). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Spiti A, Caldirola D, Perna G (2026). \textit{New Antidepressant Development in the Treatment of Depression.}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Olivier B, Olivier JDA (2026). \textit{Psychedelics: Future Therapeutics in Major Depression?}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-95-6872-7\_25}{doi:10.1007/978-981-95-6872-7\_25}.
\item Kirlić N, Atli M, Mistry S, Gold M, Goodwin GM (2026). \textit{The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002119}{doi:10.1097/jcp.0000000000002119}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2026). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Geraci J, Viirre E, Qorri B, Pani L (2026). \textit{Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2026.1777613}{doi:10.3389/fphar.2026.1777613}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Aneta Petrušková (2025). \textit{Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity}. OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg. [published; OpenAlex]. \href{https://doi.org/10.25593/open-fau-2619}{doi:10.25593/open-fau-2619}.
\item NYU Langone Health (2025). \textit{Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296328}{source link}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Matthews Nicholass K, Flis I, Hanley M, Knight M, Lane S, Littlejohn G, Thom M, Billington R, Boden R, Cummins R, Green B, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis J. (2025). \textit{Wherefore the magic? The evolutionary role of psilocybin in nature}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694186}{doi:10.64898/2025.12.17.694186}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Ledwos N, Baer J, Husain MI, Blumberger DM, Patterson R, Hollingdrake E, Cheung E, Hawco C, Zrenner C, Zrenner B, Feusner JD, Rossell SL, Castle DJ, Zai G (2025). \textit{Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2025.10895}{doi:10.1192/bjo.2025.10895}.
\item Jake Hooper, Sarah Williams, Raeghan Mueller, Kent Hutchison (2025). \textit{Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v2}{source link}.
\item Magee Sarah N., Sereno Allison C., Echeveste-Sanchez Maria, Shannon Elizabeth G., Mohsin Abir, Mott Sarah E., Faccidomo Sara P., Hodge Clyde W., Herman Melissa A. (2025). \textit{The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice}. The Journal of Neuroscience. [published; Crossref]. \href{https://doi.org/10.1523/jneurosci.0652-25.2025}{doi:10.1523/jneurosci.0652-25.2025}.
\item Imperial College London (2025). \textit{Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06798636}{source link}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item University of British Columbia (2025). \textit{Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05585229}{source link}.
\item NYU Langone Health (2025). \textit{A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05398484}{source link}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Drewko AJ, Habets RLP, Brunt TM (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Modlin NL, Williamson V, Goodwin GM, Malievskaia E, Atli M, Elek Z, Gaillard A, Koelpin D, Cleare A, Agrawal M, Yehuda R, Kirlic N, Rucker J (2025). \textit{Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2025.103692}{doi:10.1016/j.eclinm.2025.103692}.
\item Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item Julian Kiverstein, Hüseyin Beyköylü, Michiel van Elk (2025). \textit{A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2025.2590741}{doi:10.1080/09515089.2025.2590741}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item University College, London (2025). \textit{Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06815653}{source link}.
\item Jaster AM, Hadlock TM, Buzzi B, Maltman JL, Silva GM, Saha S, Koseli E, Pondelick AM, Thakur N, Zhang X, Li G, Ledesma-Corvi S, Moore KN, Peterson HR, Fujita B, Zylko AL, Lewis MR, Poklis JL, Halquist MS, Wolstenholme JT, Selley DE, Hamilton PJ, Lu C, Damaj MI, González-Maeso J (2025). \textit{Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-64887-w}{doi:10.1038/s41467-025-64887-w}.
\item Natoli S, Cuomo A, Marchesini M, Luongo L, Lo Bianco G, Guardamagna VA, Yamaguchi S (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical sciences (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Montgomery Tony, Grant DeMond M. (2025). \textit{Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration}. Advance. [preprint; Crossref]. \href{https://doi.org/10.31124/advance.175630073.36585408/v2}{doi:10.31124/advance.175630073.36585408/v2}.
\item Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item Renner AC, Kargbo RB (2025). \textit{Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00595}{doi:10.1021/acsmedchemlett.5c00595}.
\item Martens MAG, Cunha BG, Erritzoe D, Nutt D, Carhart-Harris R, Harmer CJ (2025). \textit{Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03693-w}{doi:10.1038/s41398-025-03693-w}.
\item Schäfer T, Haun F, Rupp B, Hoffmeister D (2025). \textit{Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms.}. Angewandte Chemie (International ed. in English). [published; PubMed]. \href{https://doi.org/10.1002/anie.202512017}{doi:10.1002/anie.202512017}.
\item Mehtani NJ, Mian MN, Agin-Liebes G, Coker AR, Huebner C, Anderson BT, Mitchell JM (2025). \textit{Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2583960}{doi:10.1080/02791072.2025.2583960}.
\item Zech JM, Richard J, Jones GM (2025). \textit{The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2583967}{doi:10.1080/02791072.2025.2583967}.
\item Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO. (2025). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.06.687023}{doi:10.1101/2025.11.06.687023}.
\item Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu (2025). \textit{Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-292276}{doi:10.5167/uzh-292276}.
\item Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C. (2025). \textit{Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7890051/v1}{doi:10.21203/rs.3.rs-7890051/v1}.
\item Richard Drexler, Belgin Yalçın, Rebecca Mancusi, Abigail Rogers, Kiarash Shamardani, Pamelyn J. Woo, Alexandre Ravel, Yahaya A Yabo, Carlos Alberto Oliveira de Biagi-Junior, Costanza Lo Cascio, Robert C. Malenka, Boris D. Heifets, Mariella G. Filbin, Dieter Henrik Heiland, Karl Deisseroth, Michelle Monje (2025). \textit{CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS}. Neuro-Oncology. [published; OpenAlex]. \href{https://doi.org/10.1093/neuonc/noaf201.0244}{doi:10.1093/neuonc/noaf201.0244}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Molecular neurobiology. [published; PubMed]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Rahmani S, Crupi R, Riley AL, Davidson T (2025). \textit{The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2025.174087}{doi:10.1016/j.pbb.2025.174087}.
\item Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML (2025). \textit{N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-025-02190-4}{doi:10.1038/s41386-025-02190-4}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Hammo A, Wisser S, Cichon J (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Washington University School of Medicine (2025). \textit{Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04501653}{source link}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Pu Jiang, Cong Lin, Xiaohui Wang (2025). \textit{Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025p.0041}{doi:10.61373/pp025p.0041}.
\item Gabriele M. König, Li-Ming Hsu, Yi-Ting Chiu, Gavin P. Schmitz, Martin MacKinnon, Yen-Yu I. Shih, Bryan L. Roth, Sarah N. Magee, Evi Kostenis, Melissa A. Herman, Mia L. Foglesong (2025). \textit{Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/ce6e-4888}{doi:10.17615/ce6e-4888}.
\item Shadani S, Greaves E, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.14.682467}{doi:10.1101/2025.10.14.682467}.
\item Sha Jin, H.Y. Wang, Xiaohui Wang (2025). \textit{Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025v.0038}{doi:10.61373/pp025v.0038}.
\item Razidlo J, Cataldo N, Wenthur CJ (2025). \textit{Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00462}{doi:10.1021/acsptsci.5c00462}.
\item Renee Ireland (2025). \textit{Psychedelics in Practice: Science, Safety, and the Future of Healing}. The proceedings of sliit international conference on advancements in science and humanities. [published; OpenAlex]. \href{https://doi.org/10.54389/epsd8792}{doi:10.54389/epsd8792}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani T, Preller KH, Taylor JP, Waters F, Winston BS, Leptourgos P (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.}. Schizophrenia bulletin. [published; PubMed]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali (2025). \textit{Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders}. Journal of Pharma Insights and Research.. [published; OpenAlex]. \href{https://doi.org/10.69613/thv1dn30}{doi:10.69613/thv1dn30}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item Richardson B, Inserra A, Pileggi M, Prud'Homme T, Bruno V, Wan-Yan-Chan D, Shareghi-Ghahreman I, Nasini S, Strand T, Leyton M, Sonenberg N, De Gregorio D, Sprouse J, Bambico FR, Gobbi G (2025). \textit{Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111522}{doi:10.1016/j.pnpbp.2025.111522}.
\item de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC (2025). \textit{Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111534}{doi:10.1016/j.pnpbp.2025.111534}.
\item Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK. (2025). \textit{Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.30.677638}{doi:10.1101/2025.09.30.677638}.
\item Afrooghe Arya, Ahmadi Elham, Lesani Ali, Mehranjani Mahya Soleymani, Elahi Mohammad, Babaei Mohammadreza, Shayan Maryam, Shafaroodi Hamed, Jafari Razieh Mohammad, Foroumadi Alireza, Manavi Mohammad Amin, Dehpour Ahmad-Reza (2025). \textit{Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway}. Naunyn-Schmiedeberg's Archives of Pharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00210-025-04152-5}{doi:10.1007/s00210-025-04152-5}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.}. Comprehensive psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L, Boffa M, Zoratto F, Borgi M, Guidotti R, Lorenzo GD, D'Addario C, Pettorruso M, Martinotti G (2025). \textit{Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116697}{doi:10.1016/j.psychres.2025.116697}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD (2025). \textit{Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Poster Abstracts. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Egger, Klemens, Meling, Daniel, Polat, Firuze, Seifritz, Erich, Avram, Mihai, Scheidegger, Milan (2025). \textit{Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-280470}{doi:10.5167/uzh-280470}.
\item Hunt T. (2025). \textit{Electrodynamics of the Psychedelic Experience}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202509.1813.v1}{doi:10.20944/preprints202509.1813.v1}.
\item Delgado-Sallent C, Ahmed SA, Khawaja-Lopez A, Lee BS, Senne R, Scott BB, Ramirez S. (2025). \textit{Psychedelics Relax Priors and Reshape Orbitofrontal Dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.18.677110}{doi:10.1101/2025.09.18.677110}.
\item Calin A, Burlec AF, Mircea C, Macovei I, Hancianu M, Corciova A (2025). \textit{Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm14186613}{doi:10.3390/jcm14186613}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2025). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.15.676273}{doi:10.1101/2025.09.15.676273}.
\item Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910) (2025). \textit{Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00647.s001}{doi:10.1021/acschemneuro.5c00647.s001}.
\item Masjedi NS, Razi A. (2025). \textit{Effective connectivity of the human claustrum: Triple networks, subcortical circuits, and psychedelic modulation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.07.674759}{doi:10.1101/2025.09.07.674759}.
\item Chwyl C, Spata A, Lucas W, Luoma JB. (2025). \textit{Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7266162/v1}{doi:10.21203/rs.3.rs-7266162/v1}.
\item Tereza Dleštíková (2025). \textit{The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030034}{doi:10.3390/psychoactives4030034}.
\item Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett (2025). \textit{Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00461}{doi:10.1556/2054.2025.00461}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Gregor Hasler (2025). \textit{Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0032}{doi:10.61373/pp025k.0032}.
\item M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030030}{doi:10.3390/psychoactives4030030}.
\item Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna (2025). \textit{PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.3(47).2025.3650}{doi:10.31435/ijitss.3(47).2025.3650}.
\item McCoy K, Reed F, Conn K, Foldi CJ (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.}. Physiology \& behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.physbeh.2025.114957}{doi:10.1016/j.physbeh.2025.114957}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Curr Microbiol. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item Keller MR, McKinney MG, Sen AK, Guagliardo FG, Hellwarth EB, Islam KN, Kaplan NA, Gibbons WJ, Kemmerly GE, Meers C, Wang X, Jones JA (2025). \textit{Psilocybin biosynthesis enhancement through gene source optimization.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2025.04.003}{doi:10.1016/j.ymben.2025.04.003}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa}. Physiology \& behavior. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609297819}{source link}.
\item Vella Y, Syrová K, Petrušková A, Koutrouli I, Kútna V, Pala J, Šíchová K, Nikolič M, Mazoch V, Jurok R, Kuchař M, Bendová Z, Páleníček T (2025). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251338232}{doi:10.1177/02698811251338232}.
\item Brudner RM, Kaczmarek E, Blainey MG, Schulz-Quach C, Meshkat S, Doyle Z, Lipsitz O, Offman H, Sethi R, Weiglein G, McIntyre RS, Rosenblat JD (2025). \textit{Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251346697}{doi:10.1177/02698811251346697}.
\item Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL (2025). \textit{Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01199-z}{doi:10.1007/s40263-025-01199-z}.
\item Glenn DL, Choi SH, Zimmerman RS (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Greaves MD, Barta T, Novelli L, Stoliker D, Razi A. (2025). \textit{Context-dependent structurally informed effective connectivity under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.18.671000}{doi:10.1101/2025.08.18.671000}.
\item Bilenker D, Avena NM (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item Albert Garcia-Romeu (2025). \textit{Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics?}. NPP-Digital Psychiatry and Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s44277-025-00043-y}{doi:10.1038/s44277-025-00043-y}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Madden MB, Schaefgen C, Vedak B, Kwon J, Pedra KSD, Sheats SH, Puche AC, Wolff SBE, Mathur BN (2025). \textit{Serotonin and psilocybin activate 5-HT receptors to suppress cortical signaling through the claustrum.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-62980-8}{doi:10.1038/s41467-025-62980-8}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Medical science monitor: international medical journal of experimental and clinical research. [published; PubMed]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Harsha S. Krishna (2025). \textit{Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders}. JUNIOR RESEARCHERS. [published; OpenAlex]. \href{https://doi.org/10.52340/jr.2025.03.03.09}{doi:10.52340/jr.2025.03.03.09}.
\item Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F, Aguilar-García IG (2025). \textit{Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26157638}{doi:10.3390/ijms26157638}.
\item Wang X, Jun F, Lin C, Wang X (2025). \textit{Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00418}{doi:10.1021/acschemneuro.5c00418}.
\item Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola (2025). \textit{544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.363}{doi:10.1093/ijnp/pyaf052.363}.
\item C Foldi (2025). \textit{564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359394}{source link}.
\item Abrahms ZN, Sen AK, Jones JA (2025). \textit{Pathway engineering for the biosynthesis of psychedelics.}. Current opinion in biotechnology. [published; PubMed]. \href{https://doi.org/10.1016/j.copbio.2025.103314}{doi:10.1016/j.copbio.2025.103314}.
\item Paracha N (2025). \textit{Navigating Intentional and Attentional Practices for Healing Across Psychedelic and Biofield Settings: A Comparative Ethnographic Study.}. Journal of integrative and complementary medicine. [published; PubMed]. \href{https://doi.org/10.1089/jicm.2024.0713}{doi:10.1089/jicm.2024.0713}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Fundamental \& clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Folia medica Cracoviensia. [published; PubMed]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Heidi Allen, B. Stott (2025). \textit{Preparing Social Work for Psychedelic-Assisted Therapy}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swaf031}{doi:10.1093/sw/swaf031}.
\item Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M. (2025). \textit{Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.07.30.25332422}{doi:10.1101/2025.07.30.25332422}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Rudy LM, Godlewski MM (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW. (2025). \textit{Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.18.664368}{doi:10.1101/2025.07.18.664368}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Current microbiology. [published; PubMed]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Nathan H. Heller, Frederick Streeter Barrett, Tobias Buchborn, Daniel Collerton, David Dupuis, Adam L. Halberstadt, Renaud Jardri, Tehseen N. Noorani, Katrin H. Preller, John-Paul Taylor (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) (2025). \textit{The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324.s001}{doi:10.1021/acsptsci.5c00324.s001}.
\item Kato K, Kleinhenz JM, Shin YJ, Coarfa C, Zarrabi AJ, Hecker L (2025). \textit{Psilocybin treatment extends cellular lifespan and improves survival of aged mice.}. npj aging. [published; PubMed]. \href{https://doi.org/10.1038/s41514-025-00244-x}{doi:10.1038/s41514-025-00244-x}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ (2025). \textit{Exploring serotonergic psychedelics as a treatment for personality disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110413}{doi:10.1016/j.neuropharm.2025.110413}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ (2025). \textit{Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-2529-7029}{doi:10.1055/a-2529-7029}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD (2025). \textit{5-HT receptors: Pharmacology and functional selectivity.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Wu Y, Ran J, Mo J, Wang J (2025). \textit{4-HIAA Blocks Methamphetamine-Induced Conditioned Place Preference in Mice Through Modulation of the 5-HT Pathway in the Nucleus Accumbens.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.70063}{doi:10.1111/adb.70063}.
\item University of Minnesota (2025). \textit{Visual Surround Suppression and Perceptual Expectation Under Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04424225}{source link}.
\item Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S. (2025). \textit{The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202506.1536.v1}{doi:10.20944/preprints202506.1536.v1}.
\item McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM. (2025). \textit{Molecular, haemodynamic and functional effects of LSD in the human brain}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.17.25329677}{doi:10.1101/2025.06.17.25329677}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Zhang Y, Yang L, Zhang Q, Li C, Mao F, Zhuo C (2025). \textit{The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03410-7}{doi:10.1038/s41398-025-03410-7}.
\item Erkizia-Santamaría I, Horrillo I, Martínez-Álvarez N, Pérez-Martínez D, Rivero G, Erdozain AM, Meana JJ, Ortega JE (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item Luke Lanham, Alistair R. McTaggart, James R. Falconer (2025). \textit{Is there mush-room to improve the environmental sustainability of psilocybin production?}. Journal of CO2 Utilization. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcou.2025.103137}{doi:10.1016/j.jcou.2025.103137}.
\item Erkizia-Santamaría I, Martínez-Álvarez N, Salinas-Novoa L, Meana JJ, Ortega JE (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Matthew Hicks (2025). \textit{Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06372197}{source link}.
\item Erin E. Mauney (2025). \textit{Erin Mauney: Psychedelics as modulators of the gut-brain interaction}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0020}{doi:10.61373/pp025k.0020}.
\item Frautschi PC, Singh AP, Stowe NA, Grady SM, Zahid Z, Banks MI, Yu JJ (2025). \textit{Effects of Psilocybin on Mouse Brain Microstructure.}. AJNR. American journal of neuroradiology. [published; PubMed]. \href{https://doi.org/10.3174/ajnr.a8634}{doi:10.3174/ajnr.a8634}.
\item Jungwirth J, von Rotz R, Dziobek I, Vollenweider FX, Preller KH (2025). \textit{Psilocybin increases emotional empathy in patients with major depression.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02875-0}{doi:10.1038/s41380-024-02875-0}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Expert opinion on emerging drugs. [published; PubMed]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item Viña SM (2025). \textit{Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0021}{doi:10.1089/psymed.2024.0021}.
\item Laabi Salma, LeMmon Claire, Vogel Callie, Chacon Mariana, Jimenez Victor M. (2025). \textit{Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling}. International Immunopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.intimp.2025.114940}{doi:10.1016/j.intimp.2025.114940}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item Peck SK, Brewerton TD, Fisher H, Trim J, Shao S, Modlin NL, Kim J, Finn DM, Kaye WH (2025). \textit{Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-025-01274-2}{doi:10.1186/s40337-025-01274-2}.
\item Johns Hopkins University (2025). \textit{Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01943994}{source link}.
\item Hooper J, Williams S, Mueller R, Hutchison K. (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dczw2\_v1}{doi:10.31234/osf.io/dczw2\_v1}.
\item Jake Hooper, Sarah Williams, Raeghan Mueller, Kent Hutchison (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v1}{source link}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Michael A. Wheeler (2025). \textit{Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0011}{doi:10.61373/pp025k.0011}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Hannes Kettner (2025). \textit{Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/125300}{doi:10.25560/125300}.
\item Ritika Jagdeep Shah, Ashish Sarangi (2025). \textit{Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review}. Alcoholism Treatment Quarterly. [published; OpenAlex]. \href{https://doi.org/10.1080/07347324.2025.2500345}{doi:10.1080/07347324.2025.2500345}.
\item Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R (2025). \textit{ALSUntangled \#77: Psilocybin.}. Amyotrophic lateral sclerosis \& frontotemporal degeneration. [published; PubMed]. \href{https://doi.org/10.1080/21678421.2024.2441274}{doi:10.1080/21678421.2024.2441274}.
\item Liebnau J, Betzler F, Kerber A (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Cardone P, Núñez P, Alnagger NLN, Martial C, van der Lande GJM, Sandell R, Carhart-Harris R, Gosseries O (2025). \textit{Psilocybin for disorders of consciousness: A case-report study.}. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. [published; PubMed]. \href{https://doi.org/10.1016/j.clinph.2025.02.264}{doi:10.1016/j.clinph.2025.02.264}.
\item Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D (2025). \textit{Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106132}{doi:10.1016/j.neubiorev.2025.106132}.
\item Pałasz A, Pukowiec M, Bogus K, Suszka-Świtek A, Filipczyk Ł, Mordecka-Chamera K, Worthington JJ, Sygidus M, Wojtas A, Bysiek A, Gołembiowska K (2025). \textit{Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251330783}{doi:10.1177/02698811251330783}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Neurobiology of stress. [published; PubMed]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Kylee Krivijanski, Albert Garcia-Romeu, Winston De La Haye, Clarence Locklear, Girardin Jean-Louis (2025). \textit{0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsaf090.0391}{doi:10.1093/sleep/zsaf090.0391}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Omidian H, Omidian A (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Ammineni D, Park R (2025). \textit{The compulsive eating paradigm: can psychedelics help in treating obesity?}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01186-7}{doi:10.1186/s40337-024-01186-7}.
\item A. Oliveira-Maia (2025). \textit{Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.64}{doi:10.1192/j.eurpsy.2025.64}.
\item Balabandian Mohammad, Manavi Mohammad Amin, Lesani Ali, Mohammad Jafari Razieh, Shafaroodi Hamed, Heidari Navid, Mirnajafi-Zadeh Javad, Foroumadi Alireza, Afrooghe Arya, Dehpour Ahmad Reza (2025). \textit{Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways}. Pharmacology Research \& Perspectives. [published; Crossref]. \href{https://doi.org/10.1002/prp2.70079}{doi:10.1002/prp2.70079}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Advanced science (Weinheim, Baden-Wurttemberg, Germany). [published; PubMed]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item Huang Z, Yao Y, Di R, Zhang J, Pan Y, Liu G (2025). \textit{De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli.}. Microbial biotechnology. [published; PubMed]. \href{https://doi.org/10.1111/1751-7915.70135}{doi:10.1111/1751-7915.70135}.
\item Keenan R, Haque R, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds S, Foldi C, Cowley M. (2025). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6225000/v1}{doi:10.21203/rs.3.rs-6225000/v1}.
\item Unity Health Toronto (2025). \textit{Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731335}{source link}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Robinson GI, Gerasymchuk M, Zanikov T, Gojani EG, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cruz C, Cameron M, Zahoruiko Y, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I (2025). \textit{LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18040451}{doi:10.3390/ph18040451}.
\item Meng C, Guo W, Xiao C, Wen Y, Zhu X, Zhang Q, Liang Y, Li H, Xu S, Qiu Y, Chen H, Lin WJ, Wu B (2025). \textit{Structural basis for psilocybin biosynthesis.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-58239-x}{doi:10.1038/s41467-025-58239-x}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Psilocybin in Alcohol Use Disorder With Comorbid Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06235411}{source link}.
\item Harari R, Getselter D, Elliott E (2025). \textit{The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex.}. Molecular brain. [published; PubMed]. \href{https://doi.org/10.1186/s13041-025-01191-0}{doi:10.1186/s13041-025-01191-0}.
\item Wang X, Lin C, Wang X (2025). \textit{Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00034}{doi:10.1021/acsptsci.5c00034}.
\item Thomas Hesslow (2025). \textit{Interview with Allen Kalpin and Reiko Ikemoto-Joseph: psychedelics and ISTDP}. Journal of Contemporary ISTDP. [published; OpenAlex]. \href{https://doi.org/10.70839/jejtzv59}{doi:10.70839/jejtzv59}.
\item Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq (2025). \textit{PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS}. Journal of medical \& health sciences review.. [published; OpenAlex]. \href{https://doi.org/10.62019/r713mw08}{doi:10.62019/r713mw08}.
\item Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M. (2025). \textit{Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.05.641592}{doi:10.1101/2025.03.05.641592}.
\item Craig, Danny R, Blalock, Eric M. (2025). \textit{Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?}. UKnowledge (University of Kentucky). [published; OpenAlex]. \href{https://uknowledge.uky.edu/jpns/vol2/iss1/1}{source link}.
\item Goodwin GM, Nowakowska A, Atli M, Dunlop BW, Feifel D, Hellerstein DJ, Marwood L, Shabir Z, Mistry S, Stansfield SC, Teoh E, Tsai J, Young MB, Malievskaia E (2025). \textit{Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.24m15449}{doi:10.4088/jcp.24m15449}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E (2025). \textit{The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.12.061}{doi:10.1016/j.jad.2024.12.061}.
\item Petrušková A, Guhathakurta D, Akdaş EY, Perelló-Amorós B, Frischknecht R, Weiss EM, Páleníček T, Fejtová A (2025). \textit{Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.70020}{doi:10.1111/jnc.70020}.
\item Kovacevich A, Dorney I, Bobak L, Kaelber DC, Barnett BS (2025). \textit{Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2474239}{doi:10.1080/02791072.2025.2474239}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v3}{doi:10.31234/osf.io/93x5h\_v3}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v2}{doi:10.31234/osf.io/93x5h\_v2}.
\item Anna-Leigh Hodge, Anna Forsyth, Tehseen Noorani, Suresh Muthukumaraswamy, Anna Rolleston, Patrick McHugh (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/93x5h\_v3}{source link}.
\item Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V (2025). \textit{Psychedelics and Suicide-Related Outcomes: A Systematic Review.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm14051416}{doi:10.3390/jcm14051416}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF (2025). \textit{Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.02.03.636248}{doi:10.1101/2025.02.03.636248}.
\item Lucido MJ, Dunlop BW (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T (2025). \textit{The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.}. Medicina (Kaunas, Lithuania). [published; PubMed]. \href{https://doi.org/10.3390/medicina61020278}{doi:10.3390/medicina61020278}.
\item de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL (2025). \textit{Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.}. Expert opinion on drug discovery. [published; PubMed]. \href{https://doi.org/10.1080/17460441.2025.2460674}{doi:10.1080/17460441.2025.2460674}.
\item *Zitong Wang, Yanbo Zhang, Xin-Min Li (2025). \textit{PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814968}{source link}.
\item Ferreira AE, Reis-Pina P (2025). \textit{Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.}. Journal of psychosomatic research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychores.2024.112020}{doi:10.1016/j.jpsychores.2024.112020}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA (2025). \textit{Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-024-01321-8}{doi:10.1007/s11916-024-01321-8}.
\item Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC (2025). \textit{Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16767}{doi:10.1111/add.16767}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C (2025). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Destoop M, Mohr P, Butlen F, Kéri P, Samochowiec J, De Picker L, Fiorillo A, Kuypers KPC, Dom G (2025). \textit{Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.}. European psychiatry: the journal of the Association of European Psychiatrists. [published; PubMed]. \href{https://doi.org/10.1192/j.eurpsy.2024.1806}{doi:10.1192/j.eurpsy.2024.1806}.
\item Schuler H, Zhou D, Savignac C, Cvetkovska V, Tse Y, Meccia J, Lopez J, Harutyunyan AS, Ragoussis J, Bzdok D, Bagot RC. (2025). \textit{Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.08.631940}{doi:10.1101/2025.01.08.631940}.
\item Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J (2025). \textit{Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-024-01353-0}{doi:10.1007/s11916-024-01353-0}.
\item Kelly TJ, Liu QS (2025). \textit{Exploring the therapeutic potential of psychedelics: Fear extinction mechanisms and amygdala modulation.}. Psychedelics. [published; PubMed]. \href{https://doi.org/10.61373/pp024b.0019}{doi:10.61373/pp024b.0019}.
\item Caitlyn S. Greenspun (2025). \textit{The Right to 'Trip:' Navigating Psilocybin-Assisted Psychotherapy Under the Right to Try Pathway}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://lawecommons.luc.edu/luclj/vol56/iss3/6}{source link}.
\item Machado Henrique Tofoli Vieira, Seixas Geovana Mendes de, Silva Luis Gustavo Alves, Brito Mariana Duarte Garcia, Castro Giovanna Miziara (2025). \textit{Alternative therapy for neurological and psychiatric disorders using psilocybin}. São Paulo Medical Journal. [published; Crossref]. \href{https://doi.org/10.5327/1516-3180.cpn.1123}{doi:10.5327/1516-3180.cpn.1123}.
\item Kostić Marina D., Nedić Jana, Dragojević Jovana S., Divac Vera M. (2025). \textit{In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor}. Book of Proceedings. [published; Crossref]. \href{https://doi.org/10.46793/iccbikg25.477k}{doi:10.46793/iccbikg25.477k}.
\item Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva (2025). \textit{Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v7isup.1031}{doi:10.51126/revsalus.v7isup.1031}.
\item Mile Jevtić (2025). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S (2025). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Molecular biotechnology. [published; PubMed]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Humphreys K, Todd Korthuis P, Stjepanović D, Hall W (2025). \textit{Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.}. Annual review of psychology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-psych-020124-023532}{doi:10.1146/annurev-psych-020124-023532}.
\item Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB (2025). \textit{Psilocybin: From Psychiatric Pariah to Perceived Panacea.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230682}{doi:10.1176/appi.ajp.20230682}.
\item Miller CE, Zoladz PR (2025). \textit{Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1124/jpet.124.002237}{doi:10.1124/jpet.124.002237}.
\item Godfrey K, Luan LX, Timmermann C (2025). \textit{Effects of psychedelics on human oscillatory brain activity.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.012}{doi:10.1016/bs.irn.2025.04.012}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Bostoen T, Tap S, Breeksema J, Schoevers R (2025). \textit{Post-traumatic stress disorder in psychedelic research.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.004}{doi:10.1016/bs.irn.2025.02.004}.
\item Vogt SB, Liechti ME (2025). \textit{Clinical pharmacology.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.003}{doi:10.1016/bs.irn.2025.02.003}.
\item Perez GM, Rosenberg BM, Xu W, Oathes DJ (2025). \textit{Brain changes associated with depression treatment: a meta-analysis.}. NeuroImage. Clinical. [published; PubMed]. \href{https://doi.org/10.1016/j.nicl.2025.103874}{doi:10.1016/j.nicl.2025.103874}.
\item Garcia ACM, Maia LO (2025). \textit{Psychedelic-assisted therapies for existential and spiritual suffering in palliative care.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2025.07.002}{doi:10.1016/bs.pbr.2025.07.002}.
\item Tuğcan MO, Akpınar AA (2025). \textit{Mushroom poisoning: An updated review.}. Turkish journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.4103/tjem.tjem\_129\_24}{doi:10.4103/tjem.tjem\_129\_24}.
\item Brooks BM, Cordero FJ, Alchermes SL, Brooks BM (2025). \textit{Social pain: A systematic review on interventions.}. F1000Research. [published; PubMed]. \href{https://doi.org/10.12688/f1000research.159561.1}{doi:10.12688/f1000research.159561.1}.
\item Meshkat S, J Zeifman R, Stewart K, Janssen-Aguilar R, Lou W, Jetly R, Monson CM, Bhat V (2025). \textit{Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0313741}{doi:10.1371/journal.pone.0313741}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D (2025). \textit{Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.78171}{doi:10.7759/cureus.78171}.
\item Junges LH, Müller-Santos M (2025). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Biotechnology progress. [published; PubMed]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Mauney E, King F, Burton-Murray H, Kuo B (2025). \textit{Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.}. Journal of clinical gastroenterology. [published; PubMed]. \href{https://doi.org/10.1097/mcg.0000000000002149}{doi:10.1097/mcg.0000000000002149}.
\item Neitzke-Spruill L, Beit CS, Robinson JO, Singh N, Kambala S, Ramesh R, McGuire AL (2025). \textit{A landscape analysis of psychedelic retreat organizations advertising online.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0321648}{doi:10.1371/journal.pone.0321648}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Hooper JF, Gyongyosi EL, Hutchison KE, Mueller RL (2025). \textit{Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1533055}{doi:10.3389/fpsyg.2025.1533055}.
\item Ross BM (2025). \textit{Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence.}. Frontiers in artificial intelligence. [published; PubMed]. \href{https://doi.org/10.3389/frai.2025.1589086}{doi:10.3389/frai.2025.1589086}.
\item Roseby W, Kettner H, Roseman L, Spriggs MJ, Lyons T, Peill J, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris RL (2025). \textit{Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1580663}{doi:10.3389/fpsyg.2025.1580663}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item Beneš M, Páleníček T, Horáček J (2025). \textit{What fMRI studies say about the nature of the psychedelic effect: a scoping review.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2025.1606798}{doi:10.3389/fnins.2025.1606798}.
\item Małgorzata W, Kopczyk R, Gerlach A, Rymaszewska J (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Adeyinka D, Forsyth D, Currie S, Faraone N (2025). \textit{Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.}. Frontiers in systems neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnsys.2025.1585367}{doi:10.3389/fnsys.2025.1585367}.
\item Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M (2025). \textit{Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1651898}{doi:10.3389/fphar.2025.1651898}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item Dodds C, Dawson R, Lim A, Tye S, Nasrallah F (2025). \textit{Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251396255}{doi:10.1177/20451253251396255}.
\item Ching THW, Stahnke B, Shnayder S, Agin-Liebes G, Adams TG, Amoroso L, Baiz O, Belser A, Bohner C, Burke M, D'Amico E, DePalmer G, Eilbott J, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Purohit P, Schaer H, Sierra YP, Witherow C, Pittenger C, Kelmendi B (2025). \textit{Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1726818}{doi:10.3389/fpsyt.2025.1726818}.
\item Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly (2024). \textit{Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse}. Saudi Journal of Medicine and Public Health. [published; OpenAlex]. \href{https://doi.org/10.64483/20251153}{doi:10.64483/20251153}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Deutsches Arzteblatt international. [published; PubMed]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item Koning E, Chaves C, Kirkpatrick RH, Brietzke E (2024). \textit{Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01185-8}{doi:10.1186/s40337-024-01185-8}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Gitte Moos Knudsen (2024). \textit{The Neurobiological Effect of 5-HT2AR Modulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03289949}{source link}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Enriquez-Geppert S, Krc J, O'Higgins FJ, Lietz M (2024). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.}. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. [published; PubMed]. \href{https://doi.org/10.1098/rstb.2023.0095}{doi:10.1098/rstb.2023.0095}.
\item Shabir Kanwal (2024). \textit{Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence}. Premier Journal of Science. [published; Crossref]. \href{https://doi.org/10.70389/pjs.100036}{doi:10.70389/pjs.100036}.
\item Eline Pottie, G.C. Glatfelter, M.H. Baumann, Christophe P. Stove (2024). \textit{Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2023.100109}{doi:10.1016/j.etdah.2023.100109}.
\item Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath (2024). \textit{Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia}. Alzheimer s \& Dementia. [published; OpenAlex]. \href{https://doi.org/10.1002/alz.084413}{doi:10.1002/alz.084413}.
\item Li G, Facchini PJ (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Current opinion in plant biology. [published; PubMed]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S (2024). \textit{Exploring the regulatory framework of psychedelics in the US \& Europe.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2024.104242}{doi:10.1016/j.ajp.2024.104242}.
\item Szpręgiel I, Bysiek A (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Collins HM (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item Adams DR, Allen H, Nicol GE, Cabassa LJ (2024). \textit{Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.}. Translational behavioral medicine. [published; PubMed]. \href{https://doi.org/10.1093/tbm/ibae053}{doi:10.1093/tbm/ibae053}.
\item Wood MJ, McAlpine RG, Kamboj SK (2024). \textit{Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-79931-w}{doi:10.1038/s41598-024-79931-w}.
\item Raj Nashikkar, Kavita Mane, Rajendra Patil (2024). \textit{Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials}. International Journal for Research in Applied Science and Engineering Technology. [published; OpenAlex]. \href{https://doi.org/10.22214/ijraset.2024.65160}{doi:10.22214/ijraset.2024.65160}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h}{doi:10.31234/osf.io/93x5h}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v1}{doi:10.31234/osf.io/93x5h\_v1}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Jeanblanc J, Bordy R, Fouquet G, Jeanblanc V, Naassila M (2024). \textit{Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats.}. Brain: a journal of neurology. [published; PubMed]. \href{https://doi.org/10.1093/brain/awae136}{doi:10.1093/brain/awae136}.
\item Swanson LR, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson JL, Schallmo MP (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.}. Journal of vision. [published; PubMed]. \href{https://doi.org/10.1167/jov.24.12.5}{doi:10.1167/jov.24.12.5}.
\item Zhen Z, Sun X, Yuan S, Zhang J (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Ivan VE, Tomàs-Cuesta DP, Esteves IM, Luczak A, Mohajerani M, McNaughton BL, Gruber AJ (2024). \textit{Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.}. The European journal of neuroscience. [published; PubMed]. \href{https://doi.org/10.1111/ejn.16558}{doi:10.1111/ejn.16558}.
\item Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R (2024). \textit{Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-024-01539-8}{doi:10.1007/s11920-024-01539-8}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC (2024). \textit{Expert recommendations for Germany's integration of psychedelic-assisted therapy.}. BMC medical education. [published; PubMed]. \href{https://doi.org/10.1186/s12909-024-06141-3}{doi:10.1186/s12909-024-06141-3}.
\item Lee J, Tantillo DJ, Wang LP, Fiehn O (2024). \textit{Impact of Protonation Sites on Collision-Induced Dissociation-MS/MS Using CIDMD Quantum Chemistry Modeling.}. Journal of chemical information and modeling. [published; PubMed]. \href{https://doi.org/10.1021/acs.jcim.4c00761}{doi:10.1021/acs.jcim.4c00761}.
\item de la Fuente Revenga M, González-Maeso J (2024). \textit{Snapshot of 5-HT receptor activation in the mouse brain via IP detection.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.10.11.617861}{doi:10.1101/2024.10.11.617861}.
\item Hannah Douglass (2024). \textit{The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/118978}{doi:10.25560/118978}.
\item James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu (2024). \textit{Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14846}{doi:10.1111/head.14846}.
\item Yu SJ, Wu KJ, Wang YS, Bae E, Chianelli F, Bambakidis N, Wang Y (2024). \textit{Neuroprotective effects of psilocybin in a rat model of stroke.}. BMC neuroscience. [published; PubMed]. \href{https://doi.org/10.1186/s12868-024-00903-x}{doi:10.1186/s12868-024-00903-x}.
\item Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BJ, Foldi CJ (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item Shakir J, Pedicini M, Bullock BC, Hoen PW, Macias LK, Freiman J, Pletnikov MV, Tamashiro KLK, Cordner ZA (2024). \textit{Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.}. Physiology \& behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.physbeh.2024.114627}{doi:10.1016/j.physbeh.2024.114627}.
\item Fisher EL, Smith R, Conn K, Corcoran AW, Milton LK, Hohwy J, Foldi CJ (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-024-03103-7}{doi:10.1038/s41398-024-03103-7}.
\item Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A. (2024). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4492873/v1}{doi:10.21203/rs.3.rs-4492873/v1}.
\item Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker (2024). \textit{Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2024.00058}{doi:10.37349/en.2024.00058}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Kargbo RB (2024). \textit{Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00412}{doi:10.1021/acsmedchemlett.4c00412}.
\item Kargbo RB (2024). \textit{Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00414}{doi:10.1021/acsmedchemlett.4c00414}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T (2024). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item Jacobs DS, Bogachuk AP, Le Moing CL, Moghaddam B (2024). \textit{Effects of psilocybin on uncertain punishment learning.}. Neurobiology of learning and memory. [published; PubMed]. \href{https://doi.org/10.1016/j.nlm.2024.107954}{doi:10.1016/j.nlm.2024.107954}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Loizaga-Velder A, Loizaga Pazzi A (2024). \textit{Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.}. Journal of studies on alcohol and drugs. [published; PubMed]. \href{https://doi.org/10.15288/jsad.23-00011}{doi:10.15288/jsad.23-00011}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Ask the expert - Psychedelic substances. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item University of Arizona (2024). \textit{Psilocybin for Treatment of Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03300947}{source link}.
\item Emiliano Loria, Elisabetta Lalumera, Ambra D’Imperio (2024). \textit{Psilocybin, moralization and psychotherapy: a scoping review and a case report}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2024.2389962}{doi:10.1080/09515089.2024.2389962}.
\item William M. Campo, Ann Marie Yali (2024). \textit{Psychedelic use and psychological flexibility: The role of meaningful intention and decentering}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00350}{doi:10.1556/2054.2024.00350}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Psilocybin and Salvinorin-A on Functional Connectivity}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2023/3494}{doi:10.58530/2023/3494}.
\item Vella Y, Syrova K, Petruskova A, Koutrouli I, Kutna V, Pala J, Nikolic M, Sichova K, Mazoch V, Jurok R, Kuchar M, Bendova Z, Palenicek T. (2024). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.07.606965}{doi:10.1101/2024.08.07.606965}.
\item Brugmann University Hospital (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy \& (Neuro)Cognitive Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160232}{source link}.
\item Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach (2024). \textit{Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00298-y}{doi:10.1038/s44220-024-00298-y}.
\item Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG (2024). \textit{Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2024.04.011}{doi:10.1016/j.euroneuro.2024.04.011}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Mograbi DC, Rodrigues R, Bienemann B, Huntley J (2024). \textit{Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-024-01353-y}{doi:10.1007/s11910-024-01353-y}.
\item david J, Berkovich-Ohana A, Dor-Ziderman Y. (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/tmeb3}{doi:10.31234/osf.io/tmeb3}.
\item Jonathan David, Aviva Berkovich-Ohana, ‪Yair Dor-Ziderman‬‏ (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/tmeb3\_v1}{source link}.
\item Washington University School of Medicine (2024). \textit{Psilocybin for the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05675800}{source link}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2024). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.1}{doi:10.12688/wellcomeopenres.22543.1}.
\item Bagdasarian FA, Hansen HD, Chen J, Yoo CH, Placzek MS, Hooker JM, Wey HY (2024). \textit{Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.4c00245}{doi:10.1021/acschemneuro.4c00245}.
\item de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT (2024). \textit{Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-66817-0}{doi:10.1038/s41598-024-66817-0}.
\item Kristoffer Andreas Aamodt Andersen, Bjørn Holmøy, Lowan H. Stewart (2024). \textit{Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00346}{doi:10.1556/2054.2024.00346}.
\item Ari Brouwer, Charles L. Raison, F. LeRon Shults (2024). \textit{The trajectory of psychedelic, spiritual, and psychotic experiences: implications for cognitive scientific perspectives on religion}. Religion Brain \& Behavior. [published; OpenAlex]. \href{https://doi.org/10.1080/2153599x.2024.2349151}{doi:10.1080/2153599x.2024.2349151}.
\item Poulin JM, Bigford GE, Lanctôt KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, Husain MI, Rosenblat JD, Cao X, MacIntosh BJ, Nestor SM (2024). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.}. Trials. [published; PubMed]. \href{https://doi.org/10.1186/s13063-024-08268-6}{doi:10.1186/s13063-024-08268-6}.
\item Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A (2024). \textit{Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2024.01.002}{doi:10.1016/j.biopsych.2024.01.002}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Golding P, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lotan A, Lerer L, Lerer B, Lifschytz T (2024). \textit{Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02477-w}{doi:10.1038/s41380-024-02477-w}.
\item Ramos L, Vicente SG (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Journal of clinical and experimental neuropsychology. [published; PubMed]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item Nauman Ashraf (2024). \textit{IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?}. Journal of Pakistan Psychiatric Society. [published; OpenAlex]. \href{https://doi.org/10.63050/jpps.21.02.935}{doi:10.63050/jpps.21.02.935}.
\item Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B (2024). \textit{Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.06.25.600634}{doi:10.1101/2024.06.25.600634}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Parker C, Wood BM (2024). \textit{At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.}. Social work. [published; PubMed]. \href{https://doi.org/10.1093/sw/swae019}{doi:10.1093/sw/swae019}.
\item Casanova AF, Ort A, Smallridge JW, Preller KH, Seifritz E, Vollenweider FX (2024). \textit{The influence of psilocybin on subconscious and conscious emotional learning.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2024.110034}{doi:10.1016/j.isci.2024.110034}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T. (2024). \textit{Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.594677}{doi:10.1101/2024.06.13.594677}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Linda M. Richmond (2024). \textit{Psychedelics’ Use as Medicine Hits Significant Roadblock}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.07.7.54}{doi:10.1176/appi.pn.2024.07.7.54}.
\item Linda Nguyen, Sona Regonda, Adam Gaisinsky (2024). \textit{Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.588}{doi:10.26685/urncst.588}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A (2024). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Fortschritte der Neurologie-Psychiatrie. [published; PubMed]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases}. Pharmacology \& therapeutics. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11847495}{source link}.
\item Maloney G, Ching T, Kichuk SA, Pittenger C, Kelmendi B (2024). \textit{Mechanisms of therapeutic change after psychedelic treatment in OCD.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115907}{doi:10.1016/j.psychres.2024.115907}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.05.28.596205}{doi:10.1101/2024.05.28.596205}.
\item Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML (2024). \textit{Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.05.30.596410}{doi:10.1101/2024.05.30.596410}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Hugh McGovern, Nick Wellman, Brendan Hutchinson, Lena Oestreich, Samuel E Cooper, Gregory Fonzo, Manoj Doss (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, Russell BR, Morunga E, Mills JL, Layton G, Menkes DB (2024). \textit{Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.}. Trials. [published; PubMed]. \href{https://doi.org/10.1186/s13063-024-08174-x}{doi:10.1186/s13063-024-08174-x}.
\item Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ. (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.16.594614}{doi:10.1101/2024.05.16.594614}.
\item Harari R, Chatterjee I, Getselter D, Elliott E (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Zhang R, Anguiano M, Aarrestad IK, Lin S, Chandra J, Vadde SS, Olson DE, Kim CK (2024). \textit{Rapid, biochemical tagging of cellular activity history in vivo.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.09.06.556431}{doi:10.1101/2023.09.06.556431}.
\item University of Calgary (2024). \textit{Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05995769}{source link}.
\item Patel Prince, Gollapudi Samrat, Mathew Brian Joseph, Patel Bhaumik (2024). \textit{Brain Connectivity Pattern Changes Associated With Psychedelic-Assisted Psychotherapy}. Research Poster. [published; Crossref]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Moujaes F, Rieser NM, Phillips C, de Matos NMP, Brügger M, Dürler P, Smigielski L, Stämpfli P, Seifritz E, Vollenweider FX, Anticevic A, Preller KH (2024). \textit{Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2023.07.003}{doi:10.1016/j.bpsc.2023.07.003}.
\item Geyer MA (2024). \textit{A Brief Historical Overview of Psychedelic Research.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2023.11.003}{doi:10.1016/j.bpsc.2023.11.003}.
\item Holze F, Singh N, Liechti ME, D'Souza DC (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Schmid Y, Bershad AK (2024). \textit{Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.02.001}{doi:10.1016/j.bpsc.2024.02.001}.
\item Shafiee A, Arabzadeh Bahri R, Rafiei MA, Esmaeilpur Abianeh F, Razmara P, Jafarabady K, Amini MJ (2024). \textit{The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241234247}{doi:10.1177/02698811241234247}.
\item Peill J, Marguilho M, Erritzoe D, Barba T, Greenway KT, Rosas F, Timmermann C, Carhart-Harris R (2024). \textit{Psychedelics and the 'inner healer': Myth or mechanism?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241239206}{doi:10.1177/02698811241239206}.
\item Zhao X, Du Y, Yao Y, Dai W, Yin Y, Wang G, Li Y, Zhang L (2024). \textit{Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241249436}{doi:10.1177/02698811241249436}.
\item Ruan Y, Yuan R, He J, Jiang Y, Chu S, Chen N (2024). \textit{New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.}. Cell death discovery. [published; PubMed]. \href{https://doi.org/10.1038/s41420-024-01974-9}{doi:10.1038/s41420-024-01974-9}.
\item Thomann Jan, Kolaczynska Karolina E., Stoeckmann Oliver V., Rudin Deborah, Vizeli Patrick, Hoener Marius C., Pryce Christopher R., Vollenweider Franz X., Liechti Matthias E., Duthaler Urs (2024). \textit{In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin}. Frontiers in Pharmacology. [published; Crossref]. \href{https://doi.org/10.3389/fphar.2024.1391689}{doi:10.3389/fphar.2024.1391689}.
\item Whelan TP, Daly E, Puts NA, Smith P, Allison C, Baron-Cohen S, Malievskaia E, Murphy DGM, McAlonan GM (2024). \textit{The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-024-05768-2}{doi:10.1186/s12888-024-05768-2}.
\item Seibold PS, Dörner S, Fricke J, Schäfer T, Beemelmanns C, Hoffmeister D (2024). \textit{Genetic regulation of L-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis.}. Fungal biology and biotechnology. [published; PubMed]. \href{https://doi.org/10.1186/s40694-024-00173-6}{doi:10.1186/s40694-024-00173-6}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Ivan V, Tomas-Cuesta D, Esteves I, Luczak A, Mohajerani M, McNaughton B, Gruber A. (2024). \textit{Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171378690.00112411/v1}{doi:10.22541/au.171378690.00112411/v1}.
\item Sarosh Nawaz, Abdulaziz Mohammed Althwanay, Esraa M. AlEdani MB Ch B, Harleen Kaur, Malik Kasapoglu, Rajesh Yadavalli, Ann Kashmer Yu (2024). \textit{Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review}. Journal For International Medical Graduates. [published; OpenAlex]. \href{https://doi.org/10.56570/jimgs.v1i1.155}{doi:10.56570/jimgs.v1i1.155}.
\item Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D'Souza DC (2024). \textit{Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-58318-x}{doi:10.1038/s41598-024-58318-x}.
\item Juliani A, Chelu V, Graesser L, Safron A. (2024). \textit{A dual-receptor model of serotonergic psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.12.589282}{doi:10.1101/2024.04.12.589282}.
\item Tina Singh, Dipa Patel, Kasey Bishop, Rhea Shishodia, Sadeepa Bulathsinhala (2024). \textit{Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)}. Neurology. [published; OpenAlex]. \href{https://doi.org/10.1212/wnl.0000000000206718}{doi:10.1212/wnl.0000000000206718}.
\item Kelly TJ, Bonniwell EM, Mu L, Liu X, Hu Y, Friedman V, Yu H, Su W, McCorvy JD, Liu QS (2024). \textit{Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-023-01744-8}{doi:10.1038/s41386-023-01744-8}.
\item Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK (2024). \textit{Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.}. Ageing research reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.arr.2024.102211}{doi:10.1016/j.arr.2024.102211}.
\item Tap SC (2024). \textit{The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13386}{doi:10.1111/adb.13386}.
\item M. Imad Damaj, Eda Köşeli, Belle Buzzi, Yogesh Rakholia, Melissa J. Lewis, Javier González-Maeso (2024). \textit{Pharmacology of Classical Psychedelic in Mouse Models of Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2024.01.093}{doi:10.1016/j.jpain.2024.01.093}.
\item Laabi S, LeMmon C, Vogel C, Chacon M, Jimenez VM (2024). \textit{Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights.}. International immunopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.intimp.2024.111753}{doi:10.1016/j.intimp.2024.111753}.
\item Hudspeth J, Rogge K, Dörner S, Müll M, Hoffmeister D, Rupp B, Werten S (2024). \textit{Methyl transfer in psilocybin biosynthesis.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-024-46997-z}{doi:10.1038/s41467-024-46997-z}.
\item Natalie Ertl, Matthew B. Wall (2024). \textit{Scanning the new frontier of mental health: psychedelic brain imaging}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_171}{doi:10.1042/bio\_2023\_171}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe (2024). \textit{Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-024-01253-9}{doi:10.1007/s11469-024-01253-9}.
\item Sekssaoui M, Bockaert J, Marin P, Bécamel C (2024). \textit{Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT receptor the unique player?}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-024-01794-6}{doi:10.1038/s41386-024-01794-6}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3905152/v1}{doi:10.21203/rs.3.rs-3905152/v1}.
\item Funk D, Araujo J, Slassi M, Lanthier J, Atkinson J, Feng D, Lau W, Lê A, Higgins GA (2024). \textit{Effect of a single psilocybin treatment on Fos protein expression in male rat brain.}. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroscience.2024.01.001}{doi:10.1016/j.neuroscience.2024.01.001}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. AJNR. American journal of neuroradiology. [published; PubMed]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Hatzipantelis CJ, Olson DE (2024). \textit{The Effects of Psychedelics on Neuronal Physiology.}. Annual review of physiology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-physiol-042022-020923}{doi:10.1146/annurev-physiol-042022-020923}.
\item Pagni BA, Petridis PD, Podrebarac SK, Grinband J, Claus ED, Bogenschutz MP (2024). \textit{Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-52967-8}{doi:10.1038/s41598-024-52967-8}.
\item Agin-Liebes G, Nielson EM, Zingman M, Kim K, Haas A, Owens LT, Rogers U, Bogenschutz M (2024). \textit{Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.}. Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors. [published; PubMed]. \href{https://doi.org/10.1037/adb0000935}{doi:10.1037/adb0000935}.
\item Videira NB, Nair V, Paquet V, Calhoun D (2024). \textit{The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.}. Journal of applied toxicology: JAT. [published; PubMed]. \href{https://doi.org/10.1002/jat.4533}{doi:10.1002/jat.4533}.
\item Fletcher PJ, Li Z, Ji XD, Lê AD (2024). \textit{Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT receptor agonist TCB-2 in male DBA/2J mice.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2023.173703}{doi:10.1016/j.pbb.2023.173703}.
\item De Filippo R, Schmitz D (2024). \textit{Synthetic surprise as the foundation of the psychedelic experience.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2024.105538}{doi:10.1016/j.neubiorev.2024.105538}.
\item Norred MA, Zuschlag ZD, Hamner MB (2024). \textit{A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-023-01983-5}{doi:10.1007/s40265-023-01983-5}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3010004}{doi:10.3390/psychoactives3010004}.
\item Timur Zanikov, Marta Gerasymchuk, Gregory Ian Robinson, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Mackenzie Cameron, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice}. Biocatalysis and Agricultural Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bcab.2024.103033}{doi:10.1016/j.bcab.2024.103033}.
\item Sherwood AM, Burkhartzmeyer EK, Williamson SE, Baumann MH, Glatfelter GC (2024). \textit{Psychedelic-like Activity of Norpsilocin Analogues.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.3c00610}{doi:10.1021/acschemneuro.3c00610}.
\item Marc J. Weintraub, David J. Miklowitz (2024). \textit{How should psychotherapy proceed when adjoined with psychedelics?}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21170}{doi:10.1002/wps.21170}.
\item Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M. (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5rm62}{doi:10.31234/osf.io/5rm62}.
\item Link Swanson, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D Evans, Jessica L. Nielson, Michael-Paul Schallmo (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5rm62\_v1}{source link}.
\item Duan W, Cao D, Wang S, Cheng J (2024). \textit{Serotonin 2A Receptor (5-HTR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Chemical reviews. [published; PubMed]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Jones Nathan T., Wagner Laura, Hahn Molly C. Pellitteri, Scarlett Cameron O., Wenthur Cody J. (2024). \textit{In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin}. Frontiers in Psychiatry. [published; Crossref]. \href{https://doi.org/10.3389/fpsyt.2023.1303365}{doi:10.3389/fpsyt.2023.1303365}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E. (2024). \textit{Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.04.574146}{doi:10.1101/2024.01.04.574146}.
\item Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3829237/v1}{doi:10.21203/rs.3.rs-3829237/v1}.
\item Paula Pastor Muñoz (2024). \textit{Differential effects of psychedelics and classical antidepressants on TrkB dimerization and neurotrophic signalling}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/577777}{source link}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Jaana Ruuska, Mónica Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2024). \textit{Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104774}{doi:10.1016/j.nsa.2024.104774}.
\item Prosenjit Ghosh, Avinash Desousa (2024). \textit{Psychedelics: The New Kid on the Block}. Annals of Indian Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/aip.aip\_195\_23}{doi:10.4103/aip.aip\_195\_23}.
\item Dominic Sisti (2024). \textit{Introduction to the Special Section on Psychedelics Research and Treatment}. Perspectives in biology and medicine. [published; OpenAlex]. \href{https://doi.org/10.1353/pbm.2024.a919714}{doi:10.1353/pbm.2024.a919714}.
\item Gukasyan N, Narayan SK (2024). \textit{Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2157350}{doi:10.1080/02791072.2022.2157350}.
\item Gonzales SAB, Alexopoulos C, Arkfeld DG (2024). \textit{Potential Benefits of Psilocybin for Lupus Pain: A Case Report.}. Current rheumatology reviews. [published; PubMed]. \href{https://doi.org/10.2174/1573397119666230904150750}{doi:10.2174/1573397119666230904150750}.
\item Heresco-Levy U, Lerer B (2024). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Wolinsky D, Barrett FS, Vandrey R (2024). \textit{The psychedelic effects of cannabis: A review of the literature.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231209194}{doi:10.1177/02698811231209194}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D (2024). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item Halman A, Kong G, Sarris J, Perkins D (2024). \textit{Drug-drug interactions involving classic psychedelics: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231211219}{doi:10.1177/02698811231211219}.
\item Madsen MK, Petersen AS, Stenbaek DS, Sørensen IM, Schiønning H, Fjeld T, Nykjaer CH, Larsen SMU, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM (2024). \textit{CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/head.14656}{doi:10.1111/head.14656}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R (2024). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Olivier B, Olivier JDA (2024). \textit{Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-97-4402-2\_3}{doi:10.1007/978-981-97-4402-2\_3}.
\item Vamvakopoulou IA, Nutt DJ (2024). \textit{Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.}. European addiction research. [published; PubMed]. \href{https://doi.org/10.1159/000540062}{doi:10.1159/000540062}.
\item Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF (2024). \textit{Ayahuasca for the treatment of alcohol use disorder.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2024.07.007}{doi:10.1016/bs.irn.2024.07.007}.
\item Martire G, Sipple D, Baron D, Gold MS, Lewandowski KU, Dennen CA, Sharafshah A, Elman I, Thanos PK, Modestino EJ, Badgaiyan RD, Pinhasov A, Bowirrat A, Makale M, Roy AK, Sunder K, Murphy KT, Mahajan S, Mahajan Y, Levin C, Blum K (2024). \textit{Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.}. Journal of addiction psychiatry. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39634920/}{source link}.
\item McCulloch DE, Lopez JP, Dalla C, Castrén E, Erritzoe D, Frokjaer VG, Lundberg J, Preller KH, Fisher PM, Knudsen GM (2024). \textit{Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2023.103929}{doi:10.1016/j.nsa.2023.103929}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Xu M, Kiss AJ, Jones JA, McMurray MS, Shi H (2024). \textit{Effect of oral tryptamines on the gut microbiome of rats-a preliminary study.}. PeerJ. [published; PubMed]. \href{https://doi.org/10.7717/peerj.17517}{doi:10.7717/peerj.17517}.
\item Bornemann J, Close JB, Ahmad K, Barba T, Godfrey K, Macdonald L, Erritzoe D, Nutt D, Carhart-Harris R (2024). \textit{Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1320780}{doi:10.3389/fpsyt.2024.1320780}.
\item Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G (2024). \textit{Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1406888}{doi:10.3389/fpsyt.2024.1406888}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO (2024). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Zheng S, Ma R, Yang Y, Li G (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Gobbi G (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Journal of psychiatry \& neuroscience: JPN. [published; PubMed]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT (2024). \textit{A narrative exploration of psilocybin's potential in mental health.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1429373}{doi:10.3389/fpsyt.2024.1429373}.
\item Kanis FC, Broude CN, Hellwarth EB, Gibbons WJ, Sen AK, Adams AM, Wang X, Jones JA (2024). \textit{Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities.}. Biotechnology progress. [published; PubMed]. \href{https://doi.org/10.1002/btpr.3492}{doi:10.1002/btpr.3492}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LSM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR (2024). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.}. Wellcome open research. [published; PubMed]. \href{https://doi.org/10.12688/wellcomeopenres.22543.2}{doi:10.12688/wellcomeopenres.22543.2}.
\item Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ (2023). \textit{Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2023.115775}{doi:10.1016/j.biopha.2023.115775}.
\item Verheijen Marcha C.T. (2023). \textit{Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge}. Journal of the Netherlands Society of Toxicology. [published; Crossref]. \href{https://doi.org/10.61833/jnst.2024.0002}{doi:10.61833/jnst.2024.0002}.
\item Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM. (2023). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3474764/v1}{doi:10.21203/rs.3.rs-3474764/v1}.
\item Wojtas A, Gołembiowska K (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Jingxuan Chen (2023). \textit{Application of psilocybin in mental health disorders}. Theoretical and Natural Science. [published; OpenAlex]. \href{https://doi.org/10.54254/2753-8818/21/20230859}{doi:10.54254/2753-8818/21/20230859}.
\item Robinson GI, Li D, Wang B, Rahman T, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I (2023). \textit{Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.}. Life (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/life13122345}{doi:10.3390/life13122345}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Nicoletta Faraone (2023). \textit{Flies on ’Shrooms: Studying the Psychotherapeutic Potential of Psilocybin using Drosophila}. American Entomologist. [published; OpenAlex]. \href{https://doi.org/10.1093/ae/tmad063}{doi:10.1093/ae/tmad063}.
\item Gramling R, Bennett E, Curtis K, Richards W, Rizzo DM, Arnoldy F, Hegg L, Porter J, Honstein H, Pratt S, Tarbi E, Reblin M, Thambi P, Agrawal M (2023). \textit{Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2023.0189}{doi:10.1089/jpm.2023.0189}.
\item Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AMP (2023). \textit{A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.}. Biotechnology advances. [published; PubMed]. \href{https://doi.org/10.1016/j.biotechadv.2023.108247}{doi:10.1016/j.biotechadv.2023.108247}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD, Miklowitz DJ (2023). \textit{Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0018}{doi:10.1089/psymed.2023.0018}.
\item Lennart Wiepking, Eduard J. de Bruin, Alexandra Ghiţă (2023). \textit{The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00244}{doi:10.1556/2054.2023.00244}.
\item McTaggart A, Scarlett K, Slot J, Barlow C, Appleyard C, Gardiner D, Fechner N, Tilden J, Hass D, Voogelbreinder S, Lording W, Lloyd R, Shuey L, Drenth A, James T. (2023). \textit{Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.170019739.91075425/v1}{doi:10.22541/au.170019739.91075425/v1}.
\item Schoeller F, Jain A, Adrien V, Maes P, Reggente N. (2023). \textit{Aesthetic Chills Mitigate Maladaptive Cognition In Depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3582420/v1}{doi:10.21203/rs.3.rs-3582420/v1}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A (2023). \textit{Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Van Der Walt J, Parker R (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. [published; PubMed]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Mason NL, Szabo A, Kuypers KPC, Mallaroni PA, de la Torre Fornell R, Reckweg JT, Tse DHY, Hutten NRPW, Feilding A, Ramaekers JG (2023). \textit{Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.}. Brain, behavior, and immunity. [published; PubMed]. \href{https://doi.org/10.1016/j.bbi.2023.09.004}{doi:10.1016/j.bbi.2023.09.004}.
\item Henry Harder, Fabian P. Steinmetz, Maja Kohek (2023). \textit{The Psychedelic Social Club: a regulatory concept for people who use psychedelics?}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2023.2276067}{doi:10.1080/09687637.2023.2276067}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Sarah Kratina, Chris Lo, Robert Schwartz, Carol Strike, Sydney Jopling, Ayah Nayfeh, Brian Rush (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Rieser NM, Gubser LP, Moujaes F, Duerler P, Lewis CR, Michels L, Vollenweider FX, Preller KH (2023). \textit{Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-023-44153-z}{doi:10.1038/s41598-023-44153-z}.
\item Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter (2023). \textit{Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future}. Georgetown Scientific Research Journal. [published; OpenAlex]. \href{https://doi.org/10.48091/gsr.v3i2.62}{doi:10.48091/gsr.v3i2.62}.
\item Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain (2023). \textit{Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.3050}{doi:10.1002/cpt.3050}.
\item Chloé Galipeau, Miguel Farinha-Ferreira, Jean-Charles Mariani, Samuel Diebolt, Louis Barthe, Renata Santos, Zsolt Lenkei, Ana M. Sebastião (2023). \textit{UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1116}{doi:10.1016/j.ibneur.2023.08.1116}.
\item Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová (2023). \textit{MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.608}{doi:10.1016/j.ibneur.2023.08.608}.
\item Tomáš Páleníček, Tereza Klučková, M. Nikolič, Čestmír Vejmola, Filip Tylš, Vojtěch Viktorin, Jiřı́ Horáček, Martin Brunovský (2023). \textit{DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1240}{doi:10.1016/j.ibneur.2023.08.1240}.
\item Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S (2023). \textit{Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0604}{doi:10.1089/jpm.2022.0604}.
\item Calder A, Mock S, Friedli N, Pasi P, Hasler G (2023). \textit{Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.05.008}{doi:10.1016/j.euroneuro.2023.05.008}.
\item Wolfgang AS, Hoge CW (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Syed OA, Tsang B, Gerlai R (2023). \textit{The zebrafish for preclinical psilocybin research.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105381}{doi:10.1016/j.neubiorev.2023.105381}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item University of Zurich (2023). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04141501}{source link}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item Attia E, Steinglass JE (2023). \textit{Psilocybin for anorexia nervosa: If it helps, let's learn how.}. Med (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1016/j.medj.2023.08.003}{doi:10.1016/j.medj.2023.08.003}.
\item White CM, Weisman N, Dalo J (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. The Annals of pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. International clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Fitoterapia. [published; PubMed]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Xuehan Du (2023). \textit{Pharmacology and Therapeutic Effects of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/hset.v65i.11331}{doi:10.54097/hset.v65i.11331}.
\item Nick Zagorski (2023). \textit{Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.09.9.20}{doi:10.1176/appi.pn.2023.09.9.20}.
\item Thase ME (2023). \textit{Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.mulmdd3048sho}{doi:10.4088/jcp.mulmdd3048sho}.
\item Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek (2023). \textit{Psilocybin's Emerging Role in Combating Depressive Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.40.01.011}{doi:10.12775/jehs.2023.40.01.011}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M (2023). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A (2023). \textit{Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109528}{doi:10.1016/j.neuropharm.2023.109528}.
\item Flower JE, Gibbons WJ, Adams AM, Wang X, Broude CN, Jones JA (2023). \textit{"Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli".}. Biotechnology and bioengineering. [published; PubMed]. \href{https://doi.org/10.1002/bit.28480}{doi:10.1002/bit.28480}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Rudzki S (2023). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military medicine. [published; PubMed]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lerer L, Lerer B, Lifschytz T. (2023). \textit{Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3146433/v1}{doi:10.21203/rs.3.rs-3146433/v1}.
\item Kuypers K. (2023). \textit{Psychedelics for depression: from neurobiology to treatment}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10417770}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. (2023). \textit{Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3088850/v1}{doi:10.21203/rs.3.rs-3088850/v1}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Chernoff T, Kliger B, Venturini DH (2023). \textit{[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].}. Vertex (Buenos Aires, Argentina). [published; PubMed]. \href{https://doi.org/10.53680/vertex.v34i160.463}{doi:10.53680/vertex.v34i160.463}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Skosnik PD, Sloshower J, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC (2023). \textit{Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231179800}{doi:10.1177/02698811231179800}.
\item Terri D’Arrigo (2023). \textit{Experts Offer Tips on Talking With Patients About Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.51}{doi:10.1176/appi.pn.2023.07.7.51}.
\item Hecker L, kato k, Kleinhenz JMK, Shin Y, Papageorgiou J, Zarrabi A. (2023). \textit{Psilocybin decelerates cellular senescence}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2921423/v1}{doi:10.21203/rs.3.rs-2921423/v1}.
\item Tylš Filip, Vejmola Čestmír, Koudelka Vlastimil, Piorecká Václava, Kadeřábek Lukáš, Bochin Marcel, Novák Tomáš, Kuchař Martin, Bendová Zdeňka, Brunovský Martin, Horáček Jiří, Pálení ček Tomáš (2023). \textit{Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats}. Frontiers in Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnins.2023.1152578}{doi:10.3389/fnins.2023.1152578}.
\item Wulff AB, Nichols CD, Thompson SM (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Kargbo RB (2023). \textit{Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.3c00168}{doi:10.1021/acsmedchemlett.3c00168}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.06.01.23290811}{doi:10.1101/2023.06.01.23290811}.
\item Irvine W, Tyler M, Delgoda R (2023). \textit{In silico characterization of the psilocybin biosynthesis pathway.}. Computational biology and chemistry. [published; PubMed]. \href{https://doi.org/10.1016/j.compbiolchem.2023.107854}{doi:10.1016/j.compbiolchem.2023.107854}.
\item Meyer M, Slot J (2023). \textit{The evolution and ecology of psilocybin in nature.}. Fungal genetics and biology: FG \& B. [published; PubMed]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, Antenucci L, Kot EF, Goncharuk SA, Kaurinkoski K, Kuutti M, Fred SM, Elsilä LV, Sakson S, Cannarozzo C, Diniz CRAF, Seiffert N, Rubiolo A, Haapaniemi H, Meshi E, Nagaeva E, Öhman T, Róg T, Kankuri E, Vilar M, Varjosalo M, Korpi ER, Permi P, Mineev KS, Saarma M, Vattulainen I, Casarotto PC, Castrén E (2023). \textit{Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-023-01316-5}{doi:10.1038/s41593-023-01316-5}.
\item Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM. (2023). \textit{Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.25.23290521}{doi:10.1101/2023.05.25.23290521}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Ibi D (2023). \textit{[Contribution of serotonin 5-HT receptor to antidepressant effect of serotonergic psychedelics].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Uchida H (2023). \textit{[Drugs in the Developmental Stage (Psychotropics)].}. Brain and nerve = Shinkei kenkyu no shinpo. [published; PubMed]. \href{https://doi.org/10.11477/mf.1416202356}{doi:10.11477/mf.1416202356}.
\item Braun D, Rosenberg A, Haruvi R, Malamud D, Barbara R, Kawashima T. (2023). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.04.13.536830}{doi:10.1101/2023.04.13.536830}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ (2023). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Neurochemical research. [published; PubMed]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ (2023). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Neurosurgery. [published; PubMed]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Domanegg K, Sommer WH, Meinhardt MW (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Cells. [published; PubMed]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item Ching THW, Grazioplene R, Pittenger C, Kelmendi B. (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ba42z}{doi:10.31234/osf.io/ba42z}.
\item Terence Ching, Rachael Grazioplene, Christopher Pittenger, Benjamin Kelmendi (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ba42z\_v1}{source link}.
\item Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ (2023). \textit{Canalization and plasticity in psychopathology.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109398}{doi:10.1016/j.neuropharm.2022.109398}.
\item Zanikov T, Gerasymchuk M, Ghasemi Gojani E, Robinson GI, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cameron M, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I (2023). \textit{The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules28062624}{doi:10.3390/molecules28062624}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Shi En Kim (2023). \textit{How psychedelics spark neuronal growth}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10108-scicon1}{doi:10.1021/cen-10108-scicon1}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Antioxidants (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item McTaggart AR, James TY, Slot JC, Barlow C, Fechner N, Shuey LS, Drenth A (2023). \textit{Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.}. Fungal genetics and biology: FG \& B. [published; PubMed]. \href{https://doi.org/10.1016/j.fgb.2022.103769}{doi:10.1016/j.fgb.2022.103769}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Wang Jing, Liang Min, Shang Qing, Qian Hongyan, An Ran, Liu Hua, Shao Gaojie, Li Tao, Liu Xinshe (2023). \textit{Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling}. CNS Neuroscience \& Therapeutics. [published; Crossref]. \href{https://doi.org/10.1111/cns.14054}{doi:10.1111/cns.14054}.
\item Pedicini M, Cordner ZA (2023). \textit{Utility of preclinical models in the study of psilocybin - A comprehensive review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105046}{doi:10.1016/j.neubiorev.2023.105046}.
\item Hibicke M, Kramer HM, Nichols CD (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Terri D’Arrigo (2023). \textit{Psychedelics Legislation Gains Momentum}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.4}{doi:10.1176/appi.pn.2023.03.3.4}.
\item Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF (2023). \textit{Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.}. Toxics. [published; PubMed]. \href{https://doi.org/10.3390/toxics11020148}{doi:10.3390/toxics11020148}.
\item Gonda X, Dome P, Neill JC, Tarazi FI (2023). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Mann JJ (2023). \textit{Is psilocybin an effective antidepressant and what is its Mechanism of action?}. Cell reports. Medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.xcrm.2022.100906}{doi:10.1016/j.xcrm.2022.100906}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Kaden Venugopal, Nefissa Bedri (2023). \textit{The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.420}{doi:10.26685/urncst.420}.
\item Eklund, Julia (2023). \textit{Psilocin esters - An investigation of synthetic feasibility, chemical, and metabolic stability}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.16912635}{doi:10.5281/zenodo.16912635}.
\item Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks (2023). \textit{Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231172536}{doi:10.1177/20503245231172536}.
\item McCartney AM, McGovern HT, De Foe A (2023). \textit{Predictors of Psychedelic Experience: A Thematic Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2129885}{doi:10.1080/02791072.2022.2129885}.
\item Calder AE, Hasler G (2023). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ (2023). \textit{Mescaline: The forgotten psychedelic.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R (2023). \textit{Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221125354}{doi:10.1177/02698811221125354}.
\item Buzzelli V, Carbone E, Manduca A, Schiavi S, Feo A, Perederiy JV, Ambert KH, Hausman M, Trezza V (2023). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Meccia J, Lopez J, Bagot RC (2023). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Henningfield JE, Ashworth J, Heal DJ, Smith SL (2023). \textit{Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221140004}{doi:10.1177/02698811221140004}.
\item Chen MH, Tu PC, Su TP (2023). \textit{Next generation antidepressants with novel mechanisms for treatment resistant depression.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2023.02.005}{doi:10.1016/bs.pbr.2023.02.005}.
\item Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG (2023). \textit{Biological embedding of early trauma: the role of higher prefrontal synaptic strength.}. European journal of psychotraumatology. [published; PubMed]. \href{https://doi.org/10.1080/20008066.2023.2246338}{doi:10.1080/20008066.2023.2246338}.
\item Chen Y, Liu J, Yao Y, Yan H, Su R (2023). \textit{Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1021729}{doi:10.3389/fphar.2023.1021729}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2023). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item Rankaduwa S, Owen AM (2023). \textit{Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niad001}{doi:10.1093/nc/niad001}.
\item Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A (2023). \textit{Use of Selective Alternative Therapies for Treatment of OCD.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s403997}{doi:10.2147/ndt.s403997}.
\item Urban MM, Stingl MR, Meinhardt MW (2023). \textit{Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1156319}{doi:10.3389/fnins.2023.1156319}.
\item Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D'Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B (2023). \textit{Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1178529}{doi:10.3389/fpsyt.2023.1178529}.
\item Liu J, Wang Y, Xia K, Wu J, Zheng D, Cai A, Yan H, Su R (2023). \textit{Acute psilocybin increased cortical activities in rats.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item Ratkovic G, Sosteric M, Sosteric T (2023). \textit{A case-study evaluation of the "Copenhagen Music Program" for psilocybin-assisted therapy.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1156852}{doi:10.3389/fpsyg.2023.1156852}.
\item Phan AN, Terry GE (2023). \textit{Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1144276}{doi:10.3389/fpsyt.2023.1144276}.
\item De La Haye W, Walcott G, Eaton J, Beckford J, Greene J (2023). \textit{Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1136990}{doi:10.3389/fpsyt.2023.1136990}.
\item Schindler EAD, Hendricks PS (2023). \textit{Adapting psychedelic medicine for headache and chronic pain disorders.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2023.2246655}{doi:10.1080/14737175.2023.2246655}.
\item Kozak Z, Johnson MW, Aaronson ST (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Expert opinion on pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2023). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Barnett BS, Bassir Nia A, Sackett NB, Weleff J (2023). \textit{Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1305478}{doi:10.3389/fpsyt.2023.1305478}.
\item Kovacevich A, Weleff J, Claytor B, Barnett BS (2023). \textit{Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2253538}{doi:10.1080/02791072.2023.2253538}.
\item Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B (2023). \textit{Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1278823}{doi:10.3389/fpsyt.2023.1278823}.
\item Geoffrey M. Bove, David J. Mokler (2022). \textit{Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00230}{doi:10.1556/2054.2022.00230}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. (2022). \textit{Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.15.516655}{doi:10.1101/2022.11.15.516655}.
\item Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. (2022). \textit{5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.03.515044}{doi:10.1101/2022.11.03.515044}.
\item Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh (2022). \textit{The psychedelic renaissance: can psilocybin possibly combat depression?}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000089}{doi:10.1097/gh9.0000000000000089}.
\item Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J. (2022). \textit{Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.10.31.22281688}{doi:10.1101/2022.10.31.22281688}.
\item Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR (2022). \textit{Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2022.108195}{doi:10.1016/j.pharmthera.2022.108195}.
\item Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ (2022). \textit{Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109220}{doi:10.1016/j.neuropharm.2022.109220}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Syed Rizwan A. Bokhari, Ahmad Makmom Abdullah, Zamir A. Zamir, Raquel M. Rosen (2022). \textit{A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive Emergency}. Journal of the American Society of Nephrology. [published; OpenAlex]. \href{https://doi.org/10.1681/asn.20223311s1895a}{doi:10.1681/asn.20223311s1895a}.
\item Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A (2022). \textit{Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2022-066019}{doi:10.1136/bmjopen-2022-066019}.
\item Liu Y, Guo ZJ, Zhou XW (2022). \textit{Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27196576}{doi:10.3390/molecules27196576}.
\item Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC (2022). \textit{If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.}. The journal of pain. [published; PubMed]. \href{https://doi.org/10.1016/j.jpain.2022.05.003}{doi:10.1016/j.jpain.2022.05.003}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Expert opinion on drug discovery. [published; PubMed]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE (2022). \textit{Serotonin 5-HT, 5-HT and 5-HT receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2022.113612}{doi:10.1016/j.biopha.2022.113612}.
\item Dupuis D, Veissière S (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Gobbi G, Inserra A, Greenway KT, Lifshitz M, Kirmayer LJ (2022). \textit{Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221119388}{doi:10.1177/13634615221119388}.
\item Goel DB, Zilate S (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA. (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kh3cx}{doi:10.31234/osf.io/kh3cx}.
\item Robert F. Dougherty, Patrick Clarke, Merve Alti, Joanna Kuc, Danielle Schlosser, Boadie W. Dunlop, David J. Hellerstein, Scott T. Aaronson, Sidney Zisook, Allan H Young (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kh3cx\_v1}{source link}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT receptor signaling in C57BL/6J mice.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2022). \textit{Neural mechanisms of psychedelic visual imagery}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.07.22279700}{doi:10.1101/2022.09.07.22279700}.
\item Mellner C, Dahlen M, Simonsson O (2022). \textit{Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph191811353}{doi:10.3390/ijerph191811353}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item Mitch Earleywine, Zachary Herrmann (2022). \textit{Psychedelics for Psychiatric Disorders: Promise, Not Panacea}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220810-01}{doi:10.3928/00485713-20220810-01}.
\item Brian S. Barnett, Jeremy Weleff (2022). \textit{Psychedelics in the Treatment of Substance Use Disorders}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220804-01}{doi:10.3928/00485713-20220804-01}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. (2022). \textit{Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop}. National Academies Press (US), Washington (DC). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36049038}{source link}.
\item Schindler EAD (2022). \textit{Psychedelics as preventive treatment in headache and chronic pain disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109166}{doi:10.1016/j.neuropharm.2022.109166}.
\item Johannesdottir A, Sigurdsson E (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Laeknabladid. [published; PubMed]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Charles D. Nichols (2022). \textit{Psychedelics as potent anti-inflammatory therapeutics}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2022.109232}{doi:10.1016/j.neuropharm.2022.109232}.
\item Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B (2022). \textit{Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Mushroom via Amino Acid Metabolism Pathways.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof8080870}{doi:10.3390/jof8080870}.
\item Gumpper RH, Fay JF, Roth BL (2022). \textit{Molecular insights into the regulation of constitutive activity by RNA editing of 5HT serotonin receptors.}. Cell reports. [published; PubMed]. \href{https://doi.org/10.1016/j.celrep.2022.111211}{doi:10.1016/j.celrep.2022.111211}.
\item Henner RL, Keshavan MS, Hill KP (2022). \textit{Review of potential psychedelic treatments for PTSD.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2022.120302}{doi:10.1016/j.jns.2022.120302}.
\item Gitte Moos Knudsen (2022). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04280055}{source link}.
\item Terri D’Arrigo (2022). \textit{Med Check: Psilocybin for OCD, Nuplazid Vote, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.08.8.2}{doi:10.1176/appi.pn.2022.08.8.2}.
\item Felsch CL, Kuypers KPC (2022). \textit{Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104724}{doi:10.1016/j.neubiorev.2022.104724}.
\item Golden CT, Chadderton P (2022). \textit{Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-16325-w}{doi:10.1038/s41598-022-16325-w}.
\item Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM. (2022). \textit{Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.07.10.22277414}{doi:10.1101/2022.07.10.22277414}.
\item Zeifman R, Spriggs MJ, Kettner H, Lyons T, Rosas F, Mediano P, Erritzoe D, Carhart-Harris R. (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/w8j6t}{doi:10.31234/osf.io/w8j6t}.
\item Richard J. Zeifman, Meg J Spriggs, Hannes Kettner, Taylor Lyons, Fernando Rosas, Pedro Mediano, David Erritzoe, Robin Carhart-Harris (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/w8j6t\_v1}{source link}.
\item Bosch OG, Halm S, Seifritz E (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. International journal of bipolar disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. (2022). \textit{Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.29.498015}{doi:10.1101/2022.06.29.498015}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M (2022). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Slocum ST, DiBerto JF, Roth BL (2022). \textit{Molecular insights into psychedelic drug action.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Smausz R, Neill J, Gigg J (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item McClure-Begley TD, Roth BL (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Nature reviews. Drug discovery. [published; PubMed]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA (2022). \textit{Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.}. Metabolic engineering communications. [published; PubMed]. \href{https://doi.org/10.1016/j.mec.2022.e00196}{doi:10.1016/j.mec.2022.e00196}.
\item Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG (2022). \textit{Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2066650}{doi:10.1080/14740338.2022.2066650}.
\item M Rekatsina, E Moka, A Vadalouca, G Varrassi (2022). \textit{SP56 Psychedelic drugs and pain}. Invited speakers. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2022-esra.62}{doi:10.1136/rapm-2022-esra.62}.
\item Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. (2022). \textit{Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.05.20.492842}{doi:10.1101/2022.05.20.492842}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C, Aleman Espino A, Francisco A, Borosky B, Bekheit B, Ighanifard M, Astudillo AA, Demory Beckler M (2022). \textit{Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.25235}{doi:10.7759/cureus.25235}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana (2022). \textit{Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.271}{doi:10.51126/revsalus.v4isup.271}.
\item Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK (2022). \textit{Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.}. Fungal biology. [published; PubMed]. \href{https://doi.org/10.1016/j.funbio.2022.01.003}{doi:10.1016/j.funbio.2022.01.003}.
\item Michael Avissar, Adrian Jacques H. Ambrose (2022). \textit{Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.04.4.35}{doi:10.1176/appi.pn.2022.04.4.35}.
\item Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T. (2022). \textit{Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-1321542/v1}{doi:10.21203/rs.3.rs-1321542/v1}.
\item Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. (2022). \textit{Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.03.02.22271743}{doi:10.1101/2022.03.02.22271743}.
\item Gass P, Vasilescu AN, Inta D (2022). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Der Nervenarzt. [published; PubMed]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Elman I, Pustilnik A, Borsook D (2022). \textit{Beating pain with psychedelics: Matter over mind?}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Wolff M, Mertens LJ, Walter M, Enge S, Evens R (2022). \textit{The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211073758}{doi:10.1177/02698811211073758}.
\item Thomas Christopher W., Blanco-Duque Cristina, Bréant Benjamin J., Goodwin Guy M., Sharp Trevor, Bannerman David M., Vyazovskiy Vladyslav V. (2022). \textit{Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice}. Translational Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41398-022-01846-9}{doi:10.1038/s41398-022-01846-9}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Ellen Saikku (2022). \textit{Classic psychedelics in the treatment of depression: mechanisms of action and the role of therapy}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/606412}{source link}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega (2022). \textit{Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100407}{doi:10.1016/j.nsa.2022.100407}.
\item Lucie Olejníková, Klára Šíchová, K. Chona, Hynek Danda, Tomáš Páleníček (2022). \textit{The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100948}{doi:10.1016/j.nsa.2022.100948}.
\item Daisuke Ibi (2022). \textit{Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.96.0\_4-b-s43-2}{doi:10.1254/jpssuppl.96.0\_4-b-s43-2}.
\item Daisuke Ibi (2022). \textit{Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.95.0\_3-s35-1}{doi:10.1254/jpssuppl.95.0\_3-s35-1}.
\item Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL (2022). \textit{Psychedelics and health behaviour change.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211008554}{doi:10.1177/02698811211008554}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM (2022). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211026454}{doi:10.1177/02698811211026454}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2022). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Ehrmann K, Allen JJB, Moreno FA (2022). \textit{Psilocybin for the Treatment of Obsessive-Compulsive Disorders.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_279}{doi:10.1007/7854\_2021\_279}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS (2022). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Sousa TR, Rema J, Machado S, Novais F (2022). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Current topics in medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D (2022). \textit{Psychedelic medicines for mood disorders: current evidence and clinical considerations.}. Current opinion in psychiatry. [published; PubMed]. \href{https://doi.org/10.1097/yco.0000000000000759}{doi:10.1097/yco.0000000000000759}.
\item Rieser NM, Herdener M, Preller KH (2022). \textit{Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_284}{doi:10.1007/7854\_2021\_284}.
\item Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M (2022). \textit{Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211050556}{doi:10.1177/02698811211050556}.
\item Strickland JC, Johnson MW (2022). \textit{Human behavioral pharmacology of psychedelics.}. Advances in pharmacology (San Diego, Calif.). [published; PubMed]. \href{https://doi.org/10.1016/bs.apha.2021.10.003}{doi:10.1016/bs.apha.2021.10.003}.
\item Khan AJ, Bradley E, O'Donovan A, Woolley J (2022). \textit{Psilocybin for Trauma-Related Disorders.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_366}{doi:10.1007/7854\_2022\_366}.
\item Devenot N, Seale-Feldman A, Smith E, Noorani T, Garcia-Romeu A, Johnson MW (2022). \textit{Psychedelic Identity Shift: A Critical Approach to Set And Setting.}. Kennedy Institute of Ethics journal. [published; PubMed]. \href{https://doi.org/10.1353/ken.2022.0022}{doi:10.1353/ken.2022.0022}.
\item Wang Q, Ren Y, Cui Y, Gao B, Zhang H, Jiang Q, Loor JJ, Deng Z, Xu C (2022). \textit{Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta-Serine/Threonine Kinase-Mammalian Target of Rapamycin Complex 1 Pathway.}. Frontiers in veterinary science. [published; PubMed]. \href{https://doi.org/10.3389/fvets.2022.852321}{doi:10.3389/fvets.2022.852321}.
\item Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL (2022). \textit{Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.883869}{doi:10.3389/fpsyt.2022.883869}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V (2022). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Chronic stress (Thousand Oaks, Calif.). [published; PubMed]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML (2022). \textit{Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.}. Network neuroscience (Cambridge, Mass.). [published; PubMed]. \href{https://doi.org/10.1162/netn\_a\_00250}{doi:10.1162/netn\_a\_00250}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Sottile RJ, Vida T (2022). \textit{A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.991753}{doi:10.3389/fpsyt.2022.991753}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2022). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5d7fc}{doi:10.31234/osf.io/5d7fc}.
\item Annie McCartney, Hugh McGovern, Alexander De Foe (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5d7fc\_v1}{source link}.
\item McKernan K, Kane L, Helbert Y, Zhang L, Houde N, McLaughlin S. (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.55301.2}{doi:10.12688/f1000research.55301.2}.
\item National Council of Scientific and Technical Research, Argentina (2021). \textit{Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05160220}{source link}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2021). \textit{P.0298 Evaluation of the acute mechanism of action of psilocybin in mice}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.282}{doi:10.1016/j.euroneuro.2021.10.282}.
\item Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D (2021). \textit{Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/0004867421998785}{doi:10.1177/0004867421998785}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen Und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH (2021). \textit{Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.}. Science advances. [published; PubMed]. \href{https://doi.org/10.1126/sciadv.abh2399}{doi:10.1126/sciadv.abh2399}.
\item Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS (2021). \textit{Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-021-01706-y}{doi:10.1038/s41398-021-01706-y}.
\item Aleksandrova LR, Phillips AG (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Fitzgerald PJ (2021). \textit{Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms221910706}{doi:10.3390/ijms221910706}.
\item Zeiss R, Gahr M, Graf H (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J. (2021). \textit{Therapeutic interventions for PTSD - current evidence on the the role of psychedelics}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475922}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Wayne Hall, Michael Farrell (2021). \textit{What can we learn from the history of research on psychedelic drugs in the addictions?}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.15560}{doi:10.1111/add.15560}.
\item Waters K (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. Journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Cells. [published; PubMed]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Bao SH, Jiang H, Zhu LY, Yao G, Han PG, Wan XK, Wang K, Song TY, Liu CJ, Wang S, Zhang ZY, Zhang DY, Meng E (2021). \textit{A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.}. Cell reports. [published; PubMed]. \href{https://doi.org/10.1016/j.celrep.2021.109413}{doi:10.1016/j.celrep.2021.109413}.
\item Kevin McKernan, Liam T. Kane, Yvonne Helbert, Lei Zhang, Nathan Houde, Stephen McLaughlin (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.5062843}{doi:10.5281/zenodo.5062843}.
\item Mertens LJ, Preller KH (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item Earleywine M, Ueno LF, Mian MN, Altman BR (2021). \textit{Cannabis-induced oceanic boundlessness.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121997099}{doi:10.1177/0269881121997099}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych open. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM. (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/64kyg}{doi:10.31234/osf.io/64kyg}.
\item Drummond E-Wen McCulloch, Gitte Moos Knudsen, Frederick Streeter Barrett, Manoj Doss, Gustavo Deco, Robin Carhart-Harris, Fernando Rosas, Katrin Preller, Johannes Ramaekers, Natasha Mason (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/64kyg\_v1}{source link}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Kelly JR, Crockett MT, Alexander L, Haran M, Baker A, Burke L, Brennan C, O'Keane V (2021). \textit{Psychedelic science in post-COVID-19 psychiatry.}. Irish journal of psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/ipm.2020.94}{doi:10.1017/ipm.2020.94}.
\item Evan Lewis-Healey, Ruben Eero Laukkonen, Michiel van Elk (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1037/pne0000290}{doi:10.1037/pne0000290}.
\item Lewis-Healey E, Laukkonen RE, van Elk M. (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q3ymd}{doi:10.31234/osf.io/q3ymd}.
\item Wayne Hall (2021). \textit{The need for publicly funded research on therapeutic use of psychedelic drugs}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20847}{doi:10.1002/wps.20847}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark (2021). \textit{Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling}. The FASEB Journal. [published; Crossref]. \href{https://doi.org/10.1096/fasebj.2021.35.s1.03168}{doi:10.1096/fasebj.2021.35.s1.03168}.
\item Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam (2021). \textit{Effectiveness of Psilocybin on Depression: A Qualitative Study}. Electronic Journal of General Medicine. [published; OpenAlex]. \href{https://doi.org/10.29333/ejgm/10862}{doi:10.29333/ejgm/10862}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Mason NL, Kuypers KPC, Reckweg JT, Müller F, Tse DHY, Da Rios B, Toennes SW, Stiers P, Feilding A, Ramaekers JG (2021). \textit{Spontaneous and deliberate creative cognition during and after psilocybin exposure.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-021-01335-5}{doi:10.1038/s41398-021-01335-5}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Bottemanne H, Claret A, Fossati P (2021). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item Savalia NK, Shao LX, Kwan AC (2021). \textit{A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.}. Trends in neurosciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tins.2020.11.008}{doi:10.1016/j.tins.2020.11.008}.
\item Simonsson O, Sexton JD, Hendricks PS (2021). \textit{Associations between lifetime classic psychedelic use and markers of physical health.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121996863}{doi:10.1177/0269881121996863}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R. (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8vks6}{doi:10.31234/osf.io/8vks6}.
\item Pedro Teixeira, Matthew Johnson, Christopher Timmermann, Rosalind Watts, David Erritzoe, Hannah Douglass, Hannes Kettner, Robin Carhart-Harris (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8vks6\_v1}{source link}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Odland AU, Kristensen JL, Andreasen JT (2021). \textit{Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2020.113093}{doi:10.1016/j.bbr.2020.113093}.
\item Healy CJ (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Patocka J, Wu R, Nepovimova E, Valis M, Wu W, Kuca K (2021). \textit{Chemistry and Toxicology of Major Bioactive Substances in Mushrooms.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms22042218}{doi:10.3390/ijms22042218}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2021). \textit{Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.16.431276}{doi:10.1101/2021.02.16.431276}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.03.429325}{doi:10.1101/2021.02.03.429325}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.01.28.428377}{doi:10.1101/2021.01.28.428377}.
\item Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers (2021). \textit{Behandeling met psilocybine}. Data Archiving and Networked Services (DANS). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429}{source link}.
\item Breeksema JJ, Koolen MHB, Somers M, Schoevers RA (2021). \textit{[Treatment with psilocybin: applications for patients with psychiatric disorders].}. Nederlands tijdschrift voor geneeskunde. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/33560605/}{source link}.
\item Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM (2021). \textit{Effects of a single dose of psilocybin on behaviour, brain 5-HT receptor occupancy and gene expression in the pig.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2020.11.013}{doi:10.1016/j.euroneuro.2020.11.013}.
\item Inserra A, De Gregorio D, Gobbi G (2021). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Bouso JC, Ona G, Dos Santos RG, Hallak JEC (2021). \textit{Psychedelic Medicines in Major Depression: Progress and Future Challenges.}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-33-6044-0\_26}{doi:10.1007/978-981-33-6044-0\_26}.
\item Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E (2021). \textit{Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.586682}{doi:10.3389/fpsyt.2021.586682}.
\item Castro Santos H, Gama Marques J (2021). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Porto biomedical journal. [published; PubMed]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Winkelman MJ (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE (2021). \textit{The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.}. Risk management and healthcare policy. [published; PubMed]. \href{https://doi.org/10.2147/rmhp.s300656}{doi:10.2147/rmhp.s300656}.
\item Diab H, Malcolm B (2021). \textit{Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT).}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1847366}{doi:10.1080/02791072.2020.1847366}.
\item Eleftheriou ME, Thomas E (2021). \textit{Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.707057}{doi:10.3389/fpsyt.2021.707057}.
\item de Vos CMH, Mason NL, Kuypers KPC (2021). \textit{Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.724606}{doi:10.3389/fpsyt.2021.724606}.
\item Rodríguez Arce JM, Winkelman MJ (2021). \textit{Psychedelics, Sociality, and Human Evolution.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2021.729425}{doi:10.3389/fpsyg.2021.729425}.
\item Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL (2021). \textit{Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.735523}{doi:10.3389/fpsyt.2021.735523}.
\item Whitfield HJ (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL (2021). \textit{H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2021). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G (2021). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Dudysová Daniela, Janku Karolina, Smotek Michal, Saifutdinova Elizaveta, Koprivova Jana, Bušková Jitka, Mander Bryce Anthony, Brunovský Martin, Zach Peter, Korčák Jakub, Andrashko Veronika, Viktorinová Michaela, Tylš Filip, Bravermanová Anna, Froese Tom, Páleníček Tomáš, Horáček Jiří (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Institutional Repositories DataBase (IRDB). [published; OpenAlex]. \href{http://id.nii.ac.jp/1394/00001681/}{source link}.
\item Smigielski L, Kometer M, Scheidegger M, Stress C, Preller KH, Koenig T, Vollenweider FX (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap.}. Human brain mapping. [published; PubMed]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item Courtney C. Walton, Paul Liknaitzky (2020). \textit{Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy}. Journal of Applied Sport Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/10413200.2020.1848941}{doi:10.1080/10413200.2020.1848941}.
\item University of Zurich (2020). \textit{Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03736980}{source link}.
\item Mason NL, Kuypers KPC, Müller F, Reckweg J, Tse DHY, Toennes SW, Hutten NRPW, Jansen JFA, Stiers P, Feilding A, Ramaekers JG (2020). \textit{Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-020-0718-8}{doi:10.1038/s41386-020-0718-8}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item Barrett FS, Krimmel SR, Griffiths RR, Seminowicz DA, Mathur BN (2020). \textit{Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2020.116980}{doi:10.1016/j.neuroimage.2020.116980}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Banks MI, Wenthur CJ. (2020). \textit{Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.08.12.248229}{doi:10.1101/2020.08.12.248229}.
\item Robin Carhart-Harris (2020). \textit{4 Psychedelics: therapeutic mechanisms}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2020-bnpa.4}{doi:10.1136/jnnp-2020-bnpa.4}.
\item Preller KH, Duerler P, Burt JB, Ji JL, Adkinson B, Stämpfli P, Seifritz E, Repovš G, Krystal JH, Murray JD, Anticevic A, Vollenweider FX (2020). \textit{Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2019.12.027}{doi:10.1016/j.biopsych.2019.12.027}.
\item Milne N, Thomsen P, Mølgaard Knudsen N, Rubaszka P, Kristensen M, Borodina I (2020). \textit{Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2019.12.007}{doi:10.1016/j.ymben.2019.12.007}.
\item Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E (2020). \textit{Reviewing the Potential of Psychedelics for the Treatment of PTSD.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyaa018}{doi:10.1093/ijnp/pyaa018}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Greenway KT, Garel N, Jerome L, Feduccia AA (2020). \textit{Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1772054}{doi:10.1080/17512433.2020.1772054}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Demmler R, Fricke J, Dörner S, Gressler M, Hoffmeister D (2020). \textit{S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in "Magic" Mushrooms.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.201900649}{doi:10.1002/cbic.201900649}.
\item Madsen MK, Fisher PM, Stenbæk DS, Kristiansen S, Burmester D, Lehel S, Páleníček T, Kuchař M, Svarer C, Ozenne B, Knudsen GM (2020). \textit{A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2020.02.001}{doi:10.1016/j.euroneuro.2020.02.001}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item Benko J, Vranková S (2020). \textit{Natural Psychoplastogens As Antidepressant Agents.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules25051172}{doi:10.3390/molecules25051172}.
\item Wendy Kline (2020). \textit{Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s}. Gender \& History. [published; OpenAlex]. \href{https://doi.org/10.1111/1468-0424.12471}{doi:10.1111/1468-0424.12471}.
\item Meikle SE, Liknaitzky P, Rossell SL, Ross M, Strauss N, Thomas N, Murray G, Williams M, Castle DJ (2020). \textit{Psilocybin-assisted therapy for depression: How do we advance the field?}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/0004867419888575}{doi:10.1177/0004867419888575}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR (2020). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL (2020). \textit{Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881119895520}{doi:10.1177/0269881119895520}.
\item Blei F, Dörner S, Fricke J, Baldeweg F, Trottmann F, Komor A, Meyer F, Hertweck C, Hoffmeister D (2020). \textit{Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.}. Chemistry (Weinheim an der Bergstrasse, Germany). [published; PubMed]. \href{https://doi.org/10.1002/chem.201904363}{doi:10.1002/chem.201904363}.
\item Dudysová D, Janků K, Šmotek M, Saifutdinova E, Kopřivová J, Bušková J, Mander BA, Brunovský M, Zach P, Korčák J, Andrashko V, Viktorinová M, Tylš F, Bravermanová A, Froese T, Páleníček T, Horáček J (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2020.602590}{doi:10.3389/fphar.2020.602590}.
\item Ammar Jawad (2020). \textit{Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/uresposters/356}{source link}.
\item Germann CB (2020). \textit{The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2019.109406}{doi:10.1016/j.mehy.2019.109406}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2020). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Dos Santos RG, Hallak JEC (2020). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Ho JT, Preller KH, Lenggenhager B (2020). \textit{Neuropharmacological modulation of the aberrant bodily self through psychedelics.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.006}{doi:10.1016/j.neubiorev.2019.12.006}.
\item Vermetten E, Krediet E, Bostoen T, Breeksema JJ, Schoevers RA, van den Brink W (2020). \textit{[Psychedelics in the treatment of PTSD].}. Tijdschrift voor psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/32816292/}{source link}.
\item Voineskos D, Daskalakis ZJ, Blumberger DM (2020). \textit{Management of Treatment-Resistant Depression: Challenges and Strategies.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s198774}{doi:10.2147/ndt.s198774}.
\item Wolff M, Evens R, Mertens LJ, Koslowski M, Betzler F, Gründer G, Jungaberle H (2020). \textit{Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00005}{doi:10.3389/fpsyt.2020.00005}.
\item Heuschkel K, Kuypers KPC (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ (2020). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2020.00043}{doi:10.3389/fnins.2020.00043}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris (2019). \textit{P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.593}{doi:10.1016/j.euroneuro.2019.09.593}.
\item Adams AM, Kaplan NA, Wei Z, Brinton JD, Monnier CS, Enacopol AL, Ramelot TA, Jones JA (2019). \textit{In vivo production of psilocybin in E. coli.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2019.09.009}{doi:10.1016/j.ymben.2019.09.009}.
\item Smigielski L, Kometer M, Scheidegger M, Krähenmann R, Huber T, Vollenweider FX (2019). \textit{Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-019-50612-3}{doi:10.1038/s41598-019-50612-3}.
\item Pallavicini C, Vilas MG, Villarreal M, Zamberlan F, Muthukumaraswamy S, Nutt D, Carhart-Harris R, Tagliazucchi E (2019). \textit{Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2019.06.053}{doi:10.1016/j.neuroimage.2019.06.053}.
\item Megha Satyanarayana (2019). \textit{Modified E. coli pump out psilocybin}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09739-scicon9}{doi:10.1021/cen-09739-scicon9}.
\item Johns Hopkins University (2019). \textit{Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02971605}{source link}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item King's College London (2019). \textit{A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03661125}{source link}.
\item Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK. (2019). \textit{Decreased Directed Functional Connectivity in the Psychedelic State}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/703660}{doi:10.1101/703660}.
\item Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams LA, Hui K, Hapke E (2019). \textit{Psychedelic microdosing benefits and challenges: an empirical codebook.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-019-0308-4}{doi:10.1186/s12954-019-0308-4}.
\item Carhart-Harris RL, Friston KJ (2019). \textit{REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pr.118.017160}{doi:10.1124/pr.118.017160}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR (2019). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Paul Summergrad (2019). \textit{Psychedelic Medicine: Careful Studies, Regulations Are the Answer}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.5a25}{doi:10.1176/appi.pn.2019.5a25}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL (2019). \textit{Rapid-acting antidepressants.}. Advances in pharmacology (San Diego, Calif.). [published; PubMed]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD (2019). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Current molecular pharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Corne R, Mongeau R (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Biologie aujourd'hui. [published; PubMed]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Isabella Stendahl (2018). \textit{THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749}{source link}.
\item Di Giovanni G, De Deurwaerdère P (2018). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT receptor pharmacological tool, or none of the above?}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL (2018). \textit{Effects of psilocybin therapy on personality structure.}. Acta psychiatrica Scandinavica. [published; PubMed]. \href{https://doi.org/10.1111/acps.12904}{doi:10.1111/acps.12904}.
\item Jalal B (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Blei F, Fricke J, Wick J, Slot JC, Hoffmeister D (2018). \textit{Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.201800336}{doi:10.1002/cbic.201800336}.
\item Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC (2018). \textit{Psychedelics and Personality.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00237}{doi:10.1021/acschemneuro.8b00237}.
\item Robin Carhart-Harris (2018). \textit{Serotonin, psychedelics and psychiatry}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20555}{doi:10.1002/wps.20555}.
\item Flanagan TW, Nichols CD (2018). \textit{Psychedelics as anti-inflammatory agents.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Hendricks PS (2018). \textit{Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1474185}{doi:10.1080/09540261.2018.1474185}.
\item Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, Cooley JR, Panaccione DG, Eilenberg J, Licht HHDF, Macias AM, Berger MC, Wickert KL, Stauder CM, Spahr EJ, Maust MD, Metheny AM, Simon C, Kritsky G, Hodge KT, Humber RA, Gullion T, Short DPG, Kijimoto T, Mozgai D, Arguedas N, Kasson MT. (2018). \textit{Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/375105}{doi:10.1101/375105}.
\item Thiessen MS, Walsh Z, Bird BM, Lafrance A (2018). \textit{Psychedelic use and intimate partner violence: The role of emotion regulation.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881118771782}{doi:10.1177/0269881118771782}.
\item Hoefgen S, Lin J, Fricke J, Stroe MC, Mattern DJ, Kufs JE, Hortschansky P, Brakhage AA, Hoffmeister D, Valiante V (2018). \textit{Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2018.05.014}{doi:10.1016/j.ymben.2018.05.014}.
\item Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW (2018). \textit{Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881118780612}{doi:10.1177/0269881118780612}.
\item Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA (2018). \textit{Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-018-26656-2}{doi:10.1038/s41598-018-26656-2}.
\item Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi (2018). \textit{Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22127/rjp.2018.58486}{doi:10.22127/rjp.2018.58486}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Link Swanson (2018). \textit{Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.}. Cognitive Science. [published; OpenAlex]. \href{https://escholarship.org/uc/item/67x0n7rq}{source link}.
\item Kometer M, Vollenweider FX (2018). \textit{Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_461}{doi:10.1007/7854\_2016\_461}.
\item Preller KH, Vollenweider FX (2018). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2018). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Bogenschutz MP, Ross S (2018). \textit{Therapeutic Applications of Classic Hallucinogens.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD (2018). \textit{The Effects of Hallucinogens on Gene Expression.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J (2018). \textit{Hallucinogens and Serotonin 5-HT Receptor-Mediated Signaling Pathways.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Canal CE (2018). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Handbook of experimental pharmacology. [published; PubMed]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Nielson EM, May DG, Forcehimes AA, Bogenschutz MP (2018). \textit{The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00132}{doi:10.3389/fphar.2018.00132}.
\item Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R (2018). \textit{"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.}. Cannabis and cannabinoid research. [published; PubMed]. \href{https://doi.org/10.1089/can.2017.0052}{doi:10.1089/can.2017.0052}.
\item Swanson LR (2018). \textit{Unifying Theories of Psychedelic Drug Effects.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00172}{doi:10.3389/fphar.2018.00172}.
\item Landon M. Klein (2017). \textit{If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/3bx3d6pf}{source link}.
\item University of Helsinki (2017). \textit{Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03380442}{source link}.
\item Joanna Stefaniuk (2017). \textit{„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku}. CeON Repository (Centre for Evaluation in Education and Science). [published; OpenAlex]. \href{https://depot.ceon.pl/handle/123456789/13483}{source link}.
\item Mason Marks (2017). \textit{Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3181777\_code2827981.pdf?abstractid=3065035\&mirid=1}{source link}.
\item Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV (2017). \textit{Psychedelic Drugs in Biomedicine.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2017.08.003}{doi:10.1016/j.tips.2017.08.003}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item STEVE RITTER (2017). \textit{‘Magic mushroom’ enzyme mystery solved}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09533-notw1}{doi:10.1021/cen-09533-notw1}.
\item Chris Letheby (2017). \textit{NATURALIZING PSYCHEDELIC SPIRITUALITY}. Zygon®. [published; OpenAlex]. \href{https://doi.org/10.1111/zygo.12353}{doi:10.1111/zygo.12353}.
\item Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR (2017). \textit{An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116684335}{doi:10.1177/0269881116684335}.
\item Johnson MW, Griffiths RR (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817715966}{doi:10.1177/0022167817715966}.
\item Alexander Belser, Gabrielle Agin-Liebes, Thomas Cody Swift, Sara Terrana, Neşe Devenot, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817706884}{doi:10.1177/0022167817706884}.
\item Stephen Bright, M.L. Williams, David Caldicott (2017). \textit{Should addiction researchers be interested in psychedelic science?}. Drug and Alcohol Review. [published; OpenAlex]. \href{https://doi.org/10.1111/dar.12544}{doi:10.1111/dar.12544}.
\item Dos Santos RG, Bouso JC, Hallak JEC (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR (2017). \textit{Psilocybin for treating substance use disorders?}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Nichols DE, Johnson MW, Nichols CD (2017). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Keli A. Herr (2017). \textit{Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats}. ScholarWorks - WMU (Western Michigan University). [published; OpenAlex]. \href{https://scholarworks.wmich.edu/dissertations/3170}{source link}.
\item Golden C. (2017). \textit{Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulation}. Imperial College London. [published; Europe PMC]. \href{https://doi.org/10.25560/45527}{doi:10.25560/45527}.
\item Patra S (2016). \textit{Return of the psychedelics: Psilocybin for treatment resistant depression.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2016.08.010}{doi:10.1016/j.ajp.2016.08.010}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J (2016). \textit{Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyw016}{doi:10.1093/ijnp/pyw016}.
\item Tylš Filip, Páleníček Tomáš, Kadeřábek Lukáš, Lipski Michaela, Kubešová Anna, Horáček Jiří (2016). \textit{Sex differences and serotonergic mechanisms in the behavioural effects of psilocin}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000198}{doi:10.1097/fbp.0000000000000198}.
\item Bogenschutz MP, Johnson MW (2016). \textit{Classic hallucinogens in the treatment of addictions.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2015.03.002}{doi:10.1016/j.pnpbp.2015.03.002}.
\item Dimitria Electra Gatzia, Berit Brogaard (2016). \textit{Psilocybin, LSD, Mescaline and drug-induced synesthesia}. PhilPapers (PhilPapers Foundation). [published; OpenAlex]. \href{https://philarchive.org/rec/BROPLM}{source link}.
\item Sweat NW, Bates LW, Hendricks PS (2016). \textit{The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2016.1234090}{doi:10.1080/02791072.2016.1234090}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ (2015). \textit{Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114565144}{doi:10.1177/0269881114565144}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS (2015). \textit{Recreational use, analysis and toxicity of tryptamines.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Sakashita Yuichi, Abe Kenji, Katagiri Nobuyuki, Kambe Toshie, Saitoh Toshiaki, Utsunomiya Iku, Horiguchi Yoshie, Taguchi Kyoji (2015). \textit{Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats}. Biological \textasciicircum{}|\textasciicircum{} Pharmaceutical Bulletin. [published; Crossref]. \href{https://doi.org/10.1248/bpb.b14-00315}{doi:10.1248/bpb.b14-00315}.
\item Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX (2014). \textit{Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.}. Cerebral cortex (New York, N.Y.: 1991). [published; PubMed]. \href{https://doi.org/10.1093/cercor/bht178}{doi:10.1093/cercor/bht178}.
\item Franck Vandermoere, Philippe Marin (2014). \textit{Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalization}. Receptors \& Clinical Investigation. [published; OpenAlex]. \href{https://doi.org/10.14800/rci.230}{doi:10.14800/rci.230}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths (2014). \textit{Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.02.200}{doi:10.1016/j.drugalcdep.2014.02.200}.
\item Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F (2014). \textit{Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.}. Molecular \& cellular proteomics: MCP. [published; PubMed]. \href{https://doi.org/10.1074/mcp.m113.036558}{doi:10.1074/mcp.m113.036558}.
\item Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL (2014). \textit{The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2014.00204}{doi:10.3389/fnhum.2014.00204}.
\item Javier González-Maeso (2013). \textit{EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)78457-3}{doi:10.1016/s0924-9338(14)78457-3}.
\item Icaza EE, Mashour GA (2013). \textit{Altered states: psychedelics and anesthetics.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/01.anes.0000435635.42332.ee}{doi:10.1097/01.anes.0000435635.42332.ee}.
\item Halberstadt AL, Geyer MA (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013). \textit{Broadband cortical desynchronization underlies the human psychedelic state.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.2063-13.2013}{doi:10.1523/jneurosci.2063-13.2013}.
\item Robin Carhart-Harris (2013). \textit{PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2013-306103.17}{doi:10.1136/jnnp-2013-306103.17}.
\item Young SN (2013). \textit{Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.}. Journal of psychiatry \& neuroscience: JPN. [published; PubMed]. \href{https://doi.org/10.1503/jpn.120128}{doi:10.1503/jpn.120128}.
\item Hanks JB, González-Maeso J (2013). \textit{Animal models of serotonergic psychedelics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Brogaard B (2013). \textit{Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2013.00657}{doi:10.3389/fnhum.2013.00657}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item Ümit Sayın (2012). \textit{A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens}. NeuroQuantology. [published; OpenAlex]. \href{https://doi.org/10.14704/nq.2012.10.2.528}{doi:10.14704/nq.2012.10.2.528}.
\item Johnson MW, Sewell RA, Griffiths RR (2012). \textit{Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2011.10.029}{doi:10.1016/j.drugalcdep.2011.10.029}.
\item Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX (2012). \textit{Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/npp.2011.261}{doi:10.1038/npp.2011.261}.
\item David Luke, Devin B. Terhune, Ross Friday (2012). \textit{Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia}. Seeing and Perceiving. [published; OpenAlex]. \href{https://doi.org/10.1163/187847612x646956}{doi:10.1163/187847612x646956}.
\item Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt (2011). \textit{P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(11)70495-3}{doi:10.1016/s0924-977x(11)70495-3}.
\item Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J (2011). \textit{Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2011.01.046}{doi:10.1016/j.neulet.2011.01.046}.
\item Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J (2011). \textit{Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.4230-10.2011}{doi:10.1523/jneurosci.4230-10.2011}.
\item Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson (2010). \textit{Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0014074}{doi:10.1371/journal.pone.0014074}.
\item Vollenweider FX, Kometer M (2010). \textit{The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.}. Nature reviews. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/nrn2884}{doi:10.1038/nrn2884}.
\item Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie (2010). \textit{The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series}. Cephalalgia. [published; OpenAlex]. \href{https://doi.org/10.1177/0333102410363490}{doi:10.1177/0333102410363490}.
\item Matthew J. Baggott (2009). \textit{Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/7409s4th}{source link}.
\item Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A (2009). \textit{Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.}. International journal of cardiology. [published; PubMed]. \href{https://doi.org/10.1016/j.ijcard.2007.12.064}{doi:10.1016/j.ijcard.2007.12.064}.
\item González-Maeso J, Sealfon SC (2009). \textit{Agonist-trafficking and hallucinogens.}. Current medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Kovacic P, Somanathan R (2009). \textit{Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.}. Oxidative medicine and cellular longevity. [published; PubMed]. \href{https://doi.org/10.4161/oxim.2.4.9380}{doi:10.4161/oxim.2.4.9380}.
\item Briony J. Catlow (2007). \textit{Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis}. Digital Commons - University of South Florida (University of South Florida). [published; OpenAlex]. \href{https://digitalcommons.usf.edu/etd/166}{source link}.
\item González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007). \textit{Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2007.01.008}{doi:10.1016/j.neuron.2007.01.008}.
\item Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A (2007). \textit{[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].}. Annales Academiae Medicae Stetinensis. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/20143700/}{source link}.
\item David L. Eldridge, Karin Hillenbrand (2006). \textit{Hallucinogens}. Pediatrics in Review. [published; OpenAlex]. \href{https://doi.org/10.1542/pir.27.8.314}{doi:10.1542/pir.27.8.314}.
\item Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX (2005). \textit{Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/sj.npp.1300621}{doi:10.1038/sj.npp.1300621}.
\item Saviuc P, Flesch F (2003). \textit{[Acute higher funghi mushroom poisoning and its treatment].}. Presse medicale (Paris, France: 1983). [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14534493/}{source link}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Rabin RA, Regina M, Doat M, Winter JC (2002). \textit{5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/s0091-3057(01)00720-1}{doi:10.1016/s0091-3057(01)00720-1}.
\item Bressloff PC, Cowan JD, Golubitsky M, Thomas PJ, Wiener MC (2002). \textit{What geometric visual hallucinations tell us about the visual cortex.}. Neural computation. [published; PubMed]. \href{https://doi.org/10.1162/089976602317250861}{doi:10.1162/089976602317250861}.
\item Fukuda K (2002). \textit{Possible mechanisms of panic attack and schizophrenia via APUD system.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1054/mehy.2001.1473}{doi:10.1054/mehy.2001.1473}.
\item Vollenweider FX (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Dialogues in clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vollenweider FX, Geyer MA (2001). \textit{A systems model of altered consciousness: integrating natural and drug-induced psychoses.}. Brain research bulletin. [published; PubMed]. \href{https://doi.org/10.1016/s0361-9230(01)00646-3}{doi:10.1016/s0361-9230(01)00646-3}.
\item McBride MC (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H (1999). \textit{Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0893-133x(98)00089-x}{doi:10.1016/s0893-133x(98)00089-x}.
\item Martin WR, Sloan JW (1986). \textit{Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(86)90369-2}{doi:10.1016/0091-3057(86)90369-2}.
\item McDonald A (1980). \textit{Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/070674378002500709}{doi:10.1177/070674378002500709}.
\item Trulson ME, Stark AD, Jacobs BL (1977). \textit{Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0014-2999(77)90097-8}{doi:10.1016/0014-2999(77)90097-8}.
\item Rech RH, Tilson HA, Marquis WJ (1975). \textit{Adaptive changes in behavior after repeated administration of various psychoactive drugs.}. Advances in biochemical psychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1163377/}{source link}.
\item Marc Julià, JOEL DE ROSNAY (1971). \textit{ChemInform Abstract: CHLORIERTE 2-HYDROXY- UND2-METHOXY-PHENOXYAETHYLAMINE, ANALOGA VON PSILOCYBIN}. Chemischer Informationsdienst Organische Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197110243}{doi:10.1002/chin.197110243}.
\end{enumerate}
\end{document}
